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Resumo 
As terapias celulares baseadas no transplante de células endoteliais (ECs) dentro de hidrogéis 
são hoje em dia vistas com grande interesse em estratégias de regeneração de tecidos, 
nomeadamente para o tratamento de tecidos isquémicos, visando a promoção da rápida 
(re)vascularização do implante usado para regenerar esse mesmo tecido. 
O objetivo deste trabalho prendeu-se com a optimização de um microambiente tridimensional 
(3D), capaz de proporcionar sinais celulares e de matriz, que correctamente estimulem a 
sobrevivência das ECs, e promovam a sua organização em estruturas pré-vasculares. Neste 
trabalho, foram usados hidrogéis de alginato modificado com o péptido de adesão RGD, 
previamente desenvolvidos, para cultivar diferentes tipos de ECs. Células endoteliais do 
cordão umbilical (HUVECs) e células endoteliais progenitoras (EPCs) derivadas do sangue do 
cordão umbilical (UCB) foram cultivadas em 3D, em mono-cultura ou em combinação com 
outros tipos celulares. 
Utilizando um protocolo já publicado para o isolamento de duas populações de EPCs, uma 
menos madura (er-EPCs) e outra mais madura (la-EPCs também chamadas de OECs), foram 
obtidas, respectivamente, duas populações distintas aqui designadas por UCB cells A e UCB 
cells B. As UCB cells A não expressaram o marcador endotelial CD31 e apresentaram uma 
morfologia idêntica a fibroblastos e células mesenquimais (MSCs). As UCB cells B 
apresentaram duas populações de células distintas que expressam os marcadores CD31, CD34, 
CD14 e CD45 e ainda foram capazes de internalizar ac-Dil-LDL. Estas células, apresentaram 
uma morfologia redonda e alguns agregados celulares foram detectados no poço, 
características idênticas às er-EPCs. 
Com objetivo de otimizar um microambiente num hidrogel que fosse o melhor para o 
transplante de ECs, foram estabelecidas culturas em 3D dos diferentes tipos celulares, tanto 
em mono-cultura como em co-cultura com as MSCs, utilizadas como células de suporte. Foram 
testadas as seguintes combinações: HUVECs+MSCs, UCB cells A+MSC, UCB cells B+HUVEC e 
UCB cells B+HUVECs+MSC. A presença das MSCs na cultura pareceu aumentar tanto a 
sobrevivência quanto a funcionalidade das HUVECs. Este processo poderá ter sido devido ao 
efeito que as MSCs tiveram na reorganização da matriz, uma vez que estas foram capazes de 
migrar para o centro dos discos e de criar agregados multicelulares. Estes resultados, 
juntamente com o facto de ter sido também detectada a expressão de α-SMA actina, sugerem 
que as MSCs em co-cultura com as HUVECs possam adotar um papel idêntico ao dos pericitos. 
Apesar das ECs terem sido capazes de formar estruturas tubulares nos dias 1 e 3, estas 
estruturas deixaram de ser detetadas ao dia 7. Este resultado mostra a necessidade de 
melhorar o sistema de cultura com vista a aumentar a estabilização destas estruturas ao 
longo do tempo. Quando cultivadas em 3D, as UCB cells A mantiveram uma atividade 
metabólica alta e foram capazes de contrair substancialmente a matriz, um comportamento 
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típico de fibroblastos/MSCs, organizando-se em agregados multicelulares com algumas células 
estendidas, tanto em mono-cultura como quando co-cultivadas com as MSCs. No que diz 
respeito às UCB cells B, estas não foram capazes de aumentar a sobrevivência das HUVECs 
quando em co-cultura, mas foram capazes de promover tanto a migração das células como a 
contracção da matriz, quando tri-cultivadas com as MSCs e as HUVECs. Este aumento foi 
detectado pela formação de um grande agregado no centro do disco que apresentava 
estruturas celulares bem organizadas na sua periferia. 
Apesar dos avanços descritos anteriormente, a cultura em condições 3D revelou ser uma 
tarefa desafiante, com o envolvimento de múltiplas variáveis. Assim sendo, a última parte 
desta tese foi dedicada ao desenvolvimento de uma nova plataforma de detecção de alto 
rendimento (HTS) em que uma matriz de micro-gotas de gel é produzida por uma técnica de 
bioimpressão assistida por laser (LAB). Após otimização das condições necessárias para a 
bioimpressão, foi possível bioimprimir, soluções com diferentes concentrações de alginato-
RGD (1 e 2% m/V), combinadas com agentes de gelificação (CaCO3 and GDL) e MSCs. Este 
sistema manteve-se estável durante 7 dias em cultura, período durante o qual foi mantida 
também a viabilidade celular. Com o objetivo de validar este sistema, as MSCs bioimpressas 
foram induzidas a diferenciar ao longo da linhagem osteogénica e os respectivos resultados 
foram correlacionados com os resultados obtidos em paralelo com o sistema normal de médio 
rendimento (MT). Por último, foram bioimpressas micro-gotas de HUVECs co-cultivadas com 
MSCs, obtidas pela adição dos dois tipos de células à solução de alginato. Estes resultados 
representam o primeiro passo no processo de validação da plataforma de HST proposta, que 
poderá servir com uma ferramenta útil na análise do comportamento celular em 3D, e 
consequente otimização de microambientes para a cultura de ECs.  
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Abstract 
 
Endothelial cell-based therapies in which endothelial cells (ECs) populations are delivered 
within hydrogel vehicles provide an interesting approach to the treatment of ischemic tissues, 
and can also be useful to promote the rapid vascularization of tissue-engineered constructs. 
The aim of this study was to establish optimized three-dimensional (3D) microenvironments, 
providing adequate matrix/cellular cues, for enhancing ECs survival and promoting their 
organization into pre-vascular structures. Previously developed RGD-alginate hydrogels were 
used for the 3D culture of different types of ECs, namely human umbilical vein endothelial 
cells (HUVECs) and umbilical cord blood (UCB)-derived endothelial progenitor cells (EPCs), 
which were cultured alone or in combination with other cell types. 
Following a previously published protocol for the isolation of early-EPCs and of late-EPCs (also 
known as outgrowth endothelial cells, OECs), two distinct UCB cells populations were isolated 
and characterized – hereafter designated as UCB cells A and B, respectively. Unexpectedly, 
UCB cells A lacked the expression of CD31, a prototypical endothelial marker, and presented 
a fibroblast/mesenchymal-like morphology. In contrast, UCB cells B were composed by two 
distinct cell populations that expressed CD31, CD34, CD14 and CD45, were able to uptake Ac-
Dil-LDL and presented a round shape, forming some aggregates, thus resembling early-EPCs. 
To define an optimal hydrogel-based microenvironment for ECs delivery, 3D cultures of the 
various cell types were then established, either in monoculture or in coculture with 
mesenchymal stem cells (MSCs), used as supportive cells. Different cell combinations were 
tested, namely: HUVECs+MSCs, UCB cells A+MSC, UCB cells B+HUVEC and UCB cells 
B+HUVECs+MSCs. The presence of MSCs seemed to enhance the survival and functionality of 
cocultured HUVECs, possibly by changing the matrix environment as they migrated towards 
the center of the disks forming multicellular aggregates.  They possibly also acted as 
pericyte-like cells, as suggested by the expression of α-smooth muscle actin (α-SMA). Yet, 
while ECs tubular-like assemblies were detected at days 1 and 3, these were no longer 
present at day 7, showing that further improvements of the system have to be made towards 
the stabilization of these structures. In 3D, UCB cells A cells maintained high metabolic 
activity and were able to substantially contract the matrix, a typical 
fibroblastic/mesenchymal feature, organizing into aligned multicellular aggregates with some 
sprouting cells, both in mono- and MSCs coculture. UCB cells B were not able to improve the 
survival of cocultured HUVECs, but enhanced cell migration/matrix contraction when triple-
cultured with MSCs and HUVECs, forming a large aggregate at the center of the disk that 
presented several sprouting multicellular structures at its periphery. 
The optimization of 3D culture conditions revealed to be a quite challenging task, involving 
the concomitant analysis of different variables. Thus, in the final part of this thesis, a new 
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high-throughput screening (HTS) platform was developed, consisting on cell-in-gell 3D 
microarrays produced by laser-assisted bioprinting (LAB). After optimizing the bioprinting set-
up, it was possible to print self-gelling RGD-alginate solutions at different concentrations (1 
and 2% w/v), combined with crosslinking agents (CaCO3 and GDL), and loaded with MSCs. Cell 
viability and microarray stability were preserved for up to 7 days in culture. To validate the 
system, the osteogenic differentiation of printed MSCs was tested and the results correlated 
with those observed in a standard medium-throughput (MT) assay (hydrogel disks) run in 
parallel. Finally, microarrays of cocultured HUVECs and MSCs were obtained by printing 
alginate solutions containing both cell types. These results represent a first step towards the 
validation of the proposed HTS platform, which might provide a very useful tool for analyzing 
cell behavior in 3D and, consequently, for the development of optimized 3D 
microenvironments for ECs culture. 
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Tissue engineering has been growing as an independent field over the last two decades. 
The emergence of new biomedical technologies together with advances in cell biology have 
led this field to develop as a helping tool for both normal injured tissues and tissues with 
impaired repair/regenerative ability. 
These advances have a great impact in clinical practice, allowing the development of 
procedures that were impossible to be performed until now which are starting to be used as 
well accepted therapies. For example, in 2008, a decellularized trachea was implanted in a 
patient for the first time, and latter, in 2011, the development of the first synthetic tissue-
engineered trachea was also reported. In what concerns decellularized tissues, an allogenic 
iliac vein scaffold was implanted in a 10-years-old patient, seeded with autologous 
endothelial and smooth muscle cells (SMCs) that were differentiated in vitro from bone 
marrow stromal cells, showing how promising decellularized tissues can be serving as 
scaffolds for cell therapies (1). Advances in the manipulation and creation of different types 
of biomaterials have also made possible therapies for cartilage and bone regeneration, 
employing several different strategies. Most of these therapies use biomaterials with 
autologous cells filling the existing defect in the tissues thus promoting their regeneration. 
These therapies have been used for microfractures and craniofacial reconstruction, among 
other types of applications, improving/increasing/saving patient’s lives (1). 
Despite these progresses in tissue engineering strategies, the available therapies are in 
many cases only applicable for specific tissues, which are not characterized by  complex 
vascular and/or nervous networks, as it is the case of cartilage, which is a highly avascular 
tissue lacking nervous terminals (2). Mimicking the highly complex structure of vasculature or 
nervous system is so complex that, until now, there are no sufficiently advanced strategies 
being used in clinical practice. Thus, in order to regenerate other tissues and organs, the 
development of more robust therapeutic approaches that stimulate correct vascularization 
and integration of the implant with the host vasculature are crucial (3). 
Without a perfusion blood supply, a new tissue is not able to survive and engraft 
correctly. Cells only survive if they have a capillary residing within 150-200 μm of distance (4) 
(Figure 1), which means that any biomaterial either has to degrade rapidly to allow vessels to 
grow inside and nourish the newly formed tissue, or has to create its own vascular structures 
that will eventually anastomose with the pre-existing vasculature of the host tissue. In the 
latter case, these biomaterials should be loaded with vessel-forming ECs. 
 
1. Microvascular network, vasculogenesis and angiogenesis 
 
Multicellular organisms need to distribute nutrients throughout their entire system. In 
humans, there is a complex vascular network system composed of arteries dividing 
consecutively into smaller branches like meta-arterioles (80–100mm), until ﬁnally forming 
capillaries (10–15mm) that distribute nutrients and oxygen inhaled by the lungs, recollect by-
product wastes produced by cells and have other functions like immune protection, cellular 
signalling, and endocrine interactions (5) (Figure 1). After capillaries interact with all the 
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tissues in our body, they unite into post-capillaries venules, venules and finally veins 
returning the waste products to be filtered and excreted by the excretory system, and 
returning the blood to the lungs to be oxygenated (4).  
 
 
Figure 1 – Schematic description of vascularized tissues in vivo. Diffusion and transport processes 
occur throughout all body and the surrounding tissues are supplied with oxygen, nutrients and molecular 
signaling via the vasculature. Waste products, CO2, and molecules produced by cells are exchanged with 
blood to enter into the circulation system (adapted from (6)). 
 
 
During gestation, angioblasts, that derive from the mesenchyma, cluster together, eventually 
start to form solid tubes that are the preliminary tubular structures that will originate 
arteries and veins. This process, called vasculogenesis, is responsible for the formation of the 
body blood vessel network during gestation. The formation of new vessels from the previous 
ones occurs with sprouting of cells from previous vessels, a process called angiogenesis, which 
only occurs during adulthood in pathological situations like ischemia, inflammation, wound 
healing, and hypoxia (4, 7). 
Vessels are composed of several cell types and a specific extracellular matrix (ECM) that 
functions as a scaffold where cells are going to be anchored. ECs form the lumen of vessels 
and are the main cell type responsible for the formation of the vessel network. These cells 
align with each other forming a tubular structure that will mature into capillaries. These are 
the main site of exchange of nutrients between blood and tissue, due to their capacity of 
extravasion and high surface-to-volume ratio. ECs in capillaries are covered by a basement 
membrane that is a specific ECM found in epithelial structures. In order to stabilize this 
capillary architecture, pericytes (PCs) enlace ECs and the basement membrane leading to a 
tighter structure and close interaction, allowing as well their contractile role. As capillary’s 
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diameter increases, capillaries start to be called arterioles, occurring some specific changes 
in their cellular content. The number of mural cells (PCs and SMCs) increases and precapillary 
arterioles are completely covered with SMCs that have their own basement membrane and 
interact tightly with the endothelium (8). These two cell types, SMCs and PCs, have been 
described as having an important role in stabilizing newly formed capillaries.  
Despite published descriptions that in adulthood angiogenesis only occurs in body stress 
situation and that ECs are a slow or non-replicative population (9), since 1997, a new 
paradigm has been established for vascularization in adulthood. The discovery of a new 
circulating blood cells population with postnatal vasculogenesis potential was reported by 
Ashara et al (10). These cells showed the ability of promoting or making new blood vessels 
(11-12). It was shown that not only they display several surface markers characteristic of 
endothelial lineage, but also the expression of hematopoietic antigens. These cells also 
demonstrate colony-forming ability in vitro, and are described as being promoters of vascular 
regeneration at sites of ischemia upon transplantation, which led to define these cells as 
EPCs. Since this remarkable discovery, many studies have been conducted to define EPCs and 
distinguish different populations and/or subpopulations that resemble EPCs. However, a 
definite characterization of an EPCs population is still lacking, and although some populations 
are being referred as EPCs, they can actually be other populations with some similar features 
(11, 13). 
EPCs have been explored in several therapeutic strategies (14) and are currently being 
explored in the cancer field for their role in promotion/participation in angiogenesis (8). This 
subject will be further addressed in more detail in next section. 
 
 
2. ECs in pro-angiogenic therapies: types and sources 
 
As previously mentioned, the biggest challenge in tissue engineering is the fabrication and 
regeneration of more complex and thicker tissues, as there is a need for blood supply. Since 
ECs are the main cells composing the vessels’ endothelium, much research has been 
developed aiming at using these cells to promote angiogenesis and neovascularization. 
The different ECs populations that have been used up to now have slight differences between 
them, depending on the place from where they were isolated and on the role they have to 
play. However, in general, mature ECs express a panel of common phenotypic markers, 
including von Willebrand factor (vWF), platelet endothelial cell adhesion molecule-1 (PECAM-
1 or CD31), CD34, and vascular endothelial (VE)-cadherin (VE-cad), and effectively uptake ac-
LDL (15). Although other markers can be used to identify ECs (15), these are the most 
commonly used to identify this type of cells by flow cytometry or immunohistochemistry (IHC) 
techniques (Table 1). 
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Table 1 - Endothelial Constitutive Markers (adapted from (15)). 
Endothelial Constitutive Markers 
Markers Species Cell Type Reference 
Factor VIII–related antigen h/m 
ECs (irregularly expressed by capillaries and tumor 
vessels), platelets, megakaryocytes 
(16)  
CD31/PECAM-1 h/m 
ECs, platelets, megakaryocytes, B and T lymphocyte 
subsets, monocytes, neutrophils 
(17-18)  
Angiotensin-converting enzyme h/m 
ECs, epithelial cells, monocyte-macrophages, T 
lymphocytes 
(16)  
Type I scavenger receptor 
(acetylated-LDL uptake) 
h/m ECs, macrophages, SMCs, pericytes, fibroblasts  (19) 
Ulex europaeus I agglutinin 
binding/O(H) blood-type antigen 
h ECs, erythrocytes  (20) 
Bandeirea simplicifolia lectin binding m ECs  (16) 
Griffonia simplicifoliaagglutinin 
binding 
m ECs  (21) 
Weibal-Palade bodies h/m ECs  (22) 
Vascular endothelial cadherin h/m ECs, trophoblasts, PLN sinus macrophages (23)  
CD34 h/m ECs, hemopoietic precursors (24)  
CD102/ICAM-2 h/m ECs, lymphocytes, monocytes, platelets (25)  
CD51/61 (vitronectin receptor) h/m 
ECs (overexpressed in tumor ECs), platelets, 
megakaryocytes, osteoclasts, mast cells, B 
lymphocytes 
(26)  
CD105/endoglin h 
ECs (overexpressed in tumor ECs), monocyte-
macrophages, B lymphocytes, syncytiotrophoblasts 
 (27) 
CD36 h 
Microvascular ECs, monocyte-macrophages, erythroid 
cells, platelets, megakaryocytes 
 (28) 
CD73/VAP-2 h ECs, T and B lymphocytes, tonsillar epithelium  (29) 
S-ENDO 1/MUC18 h/m 
ECs, SMCs, dendritic cells, leukocytes, melanoma 
cells, carcinoma cells 
(30)  
Thrombomodulin h/m ECs, SMCs (31)  
HEMCAM m Microvascular ECs, hemopoietic progenitors  (32) 
Sca-1 m ECs, hemopoietic precursors (33)  
AAMP h 
ECs, cytotrophoblasts, mononuclear inflammatory 
cells, melanoma cells, adenocarcinoma cells 
(34)  
 
 29 
David Boaventura Teixeira Gomes 
Interestingly, most of the markers found to be expressed by ECs, are also common to 
hematopoietic precursors or to mature blood cells, showing that both lineages have a 
common precursor (15) (Table 1). 
Human mature ECs can be isolated from different endothelium structures and cultured in 
vitro. Some populations like HUVECs, human dermal microvasculature ECs (HDMECs) and 
human vasculature ECs in general (HVECs) can be isolated and cultured with a proper 
endothelial-specific medium supplemented with adequate growth factors. However, ECs 
present slightly different behaviors, when they are sparse in culture, or confluent. When 
confluent, ECs establish cell-to-cell contact that inhibits both spontaneous and growth factor–
induced cell growth and their metabolism has some changes, like the alterations of the 
arachidonic acid metabolism, or the release of lytic enzymes or growth factors (15). These 
changes are in accordance with their normal in vivo behavior. In the endothelium, ECs are 
stable and not expected to proliferate until an injury occurs, and the endothelium is 
disrupted, leading to ECs proliferation and changing of their metabolism to recover the 
endothelium integrity, where cells establish cell-to-cell contacts, similar to what happens 
when they are confluent in vitro. 
However, it is still technically challenging to isolate mature ECs. Isolating them from a 
patient to use them as an autologous setting would cause morbidity at the donor site, as cells 
would have to be isolated from healthy vessels, and ultimately the number of cells isolated 
would be very low due to their challenging expansion process, since these cells exhibit low 
proliferation rates (6, 35).  
To overcome these difficulties, EPCs have more recently emerged as a promising source of 
ECs for neovascularization in tissue engineering strategies, due to their higher proliferative 
capacity and ability of integrating the formation of new blood vessels (11-12, 36-37). EPCs 
can be isolated from human peripheral blood (PB), bone marrow (BMw), umbilical cord blood 
(UCB) and placental tissue (36). Among all these possible sources, PB and UCB have been 
considered as the most adequate options, as both are easily collected from adult blood 
donors, or from umbilical cord blood upon birth, respectively. EPCs collected from those 
different sources share common features, such as being recruited to injured sites, and 
integrating the newly formed vessels in sites where ischemia occurs (36). 
EPCs still lack a concise, widely accepted definition, despite the advances made since the 
discovery of endothelial circulating cells with various clinical trials still ongoing. It seems that 
in blood there are different circulating cell populations that can represent EPCs in different 
stages of differentiation. The lack of a unique protocol for the isolation of these cells, and 
the lack of specific markers for their characterization, have led to different interpretations of 
different EPC-like cell populations (11). Due to this difficulty in defining what are EPCs, these 
cells are not yet postulated as a validated clinical stategy. Clinical applications require a high 
level of characterization and definition of the cells being used, as demanded by authorities 
such as the Food and Drug Administration (FDA).  
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EPCs from PB have been described as heterogeneous populations of cells and at least two 
different populations can be identified according to their appearance and morphological 
characterization (38). The first population, called er-EPCs, can be obtained from the 
mononuclear cells (MNCs) fraction of blood, after centrifugation with Ficoll gradient, upon 
being cultured for 4-7 days in fibronectin coated plate (11-12, 39-41). When in standard two-
dimensional (2D) cell culture setup, this fraction is characterized by a round to fibroblastic-
like morphology, with the formation of some cell agglomerates. These cells are thought to 
derive from blood cells and more specifically from myeloid lineages, as they are described to 
express CD45 and CD14 (38-39, 41). er-EPCs express the most common endothelial markers 
such as CD31, CD34, vWF, and VE-cad and are able to uptake ac-LDL, but are not able to form 
tubular-like structures in matrigel assay. Even though they are described to have a low 
proliferative potential, they are able to secrete proangiogenic molecules that stimulate 
angiogenesis and neovascularization (37, 42-43). In hind limb ischemia, these cells effectively 
helped the restoration of the blood network to the injured limb (37, 42-43). 
Late-EPC (la-EPCs) or, the so-called OECs is the other population that can be obtained from 
the seeding of MNCs. Using collagen type I-coated plates, as it was used here in this work, 
these cells are usually kept for 2-3 weeks in culture in an endothelial growth medium (EGM2) 
after initial sub culturing steps (39-41, 44-49). Then, the colonies start to form with cells with 
cobblestone-like morphology, very identical to mature ECs. These colonies are then isolated 
and replated to have a culture pure in OECs. In contrast to mature ECs and er-EPCs, OECs 
have a high proliferative potential, are able to form tubular-like structures in a matrigel 
assay, and also to integrate into newly-formed vessels. Like er-EPCs, OECs express CD31, 
vWF, and VE-cad, and are able to uptake ac-LDL. However, they lose CD14 and CD45 
expression, which means that they are ECs, but do not share the myeloid and blood markers, 
respectively, as er-EPCs do. Regarding CD34 expression, OECs have been described by some 
authors as expressing this hematopoietic marker (41, 48-49), while other authors 
demonstrated that these cells are CD34-negative (44, 46). CD34 expression is such an 
ambiguous characteristic to define OECs that Cheng et al (39) characterized their isolated 
population as having only 50 per cent OECs CD34+. These results altogether can lead to two 
conclusions: either there are OECs that descend from hematopoietic stem cells (HSCs) 
(belonging to the hematopoietic lineage) and OECs that do not, or all OECs are descendents 
from HSCs, but in vitro might start diverging and losing the stem potential that is 
characteristic of CD34+ cells. 
Although both EPCs populations are different, they are both capable of rescuing an ischemic 
limb when injected in an animal. This shows how these cells can be a very important tool for 
tissue engineering in the promotion and participation in neovascularization for regeneration 
therapies. All this information is summarized in a table adapted from Fuchs et al (38) and 
Yoon et al (50) (Table 2). 
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Table 2 - Overview on characteristics that distinguish between EPCs and OECs. Adapted from (38) and 
(50) 
  EPCs OECs Marker functions 
Morphology 
Spindle shaped morphology 
(50-52) 
Cobblestone-like 
morphology (44, 53-55)  
 
  
 
Appearance in culture 
After 7 days in culture (50, 
56) 
 After 2-3 weeks in culture 
(51, 53, 56)  
Human phenotypic markers CD31+ (10, 52, 57) CD31+ (53, 55, 58) 
Cell contact protein that mediates 
homotypic EC adhesion. 
 
CD45+ (52, 59) CD45- (59) 
Surface transmembrane phosphatase 
expressed in hematopoietic lineage cells. 
 
CD34+ (10, 50, 57) CD34+ (50, 59-60) Stem-cell-related marker. 
 
CD14+ (50, 52-53) CD14- (50, 53) Monocyte surface marker. 
 
CD146+ (61) CD146+ (58, 61) 
Adhesion molecule that mediates 
homotypic EC adhesion. 
 
CD133+ (60, 62-63) CD133- (59) Stem-cell-related surface marker. 
 
Flt-1+ (56) Flt-1+ (56) VEGF receptor-1. 
 
eNOS (56) eNOS (53, 56) 
Modulates VEGF-induced angiogenesis 
and vascular permeability in vivo. 
 
vWF+ (55-56, 64) vWF+ (55-56, 58) 
Constitutive glycoprotein of the 
endothelium. 
 
VE-cadherin+ (52, 56-57) VE-cadherin+ (51, 56, 58) 
Cell contact protein that mediates 
homotypic EC adhesion. 
 
KDR+ (56-57, 64) KDR+ (50, 56, 59) VEGF receptor-2. 
 
CD36+ (51) CD36+ (51) 
Receptor of TSP-1 and mediator of its 
anti-angiogenic activity 
 
Tie2+ (10, 53) Tie2+ (53) 
Cell surface receptor that bind and is 
activated by the angiopoietins. 
  
Caveolin-1 (53, 58) 
Marker of endothelial differentiation. 
Upregulated during vessel formation. 
Proliferative potential Low (50, 52, 56) High (50, 56) 
 
Tube formation No (50, 65) Yes (50, 65) 
 
Paracrine augmentation of 
angiogenesis 
Yes (66) No (66)   
 
As already stated, UCB and PB seem to be the more promising sources for the isolation of 
EPCs for tissue engineering, due to their availability and easier harvesting process. However, 
when comparing these two sources, some authors described that UCB-EPCs present higher 
anti-oxidant and migration ability with higher therapeutic efficacy comparing to PB-EPCs, in a 
hind limb ischemic disease model (36). This effect was reported as being caused by 
specifically up-regulated factors in EPCs derived from UBC, such as STMIN 1, CFL 1, PARK 7, 
NME 1, GLO 1, HSP 27 and PRDX 2. These factors seem to be key elements that could be 
functionally active in ischemic regions and promote an enhanced neovascularization process 
(36). Not only UCB-EPCs induce more neovascularization, but they also provide a safer source 
of cells in terms of immune rejection. Nuzzolo et al (67) described that UCB-EPCs have a 
lower pro-inflammatory and pro-thrombotic profile than adult EPCs. Due to the fact that EPCs 
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represent a very small fraction of the blood cells and that for cell therapies the number of 
cells necessary to a successful engraft is very high, sometimes the use of cells from different 
donors is necessary. In fact, for HSCs therapies, it was described the same pattern. HSCs from 
UCB divide more and faster than HSCs from BMw and lose less CD34+CD38- stem cell 
population throughout ex vivo expansion (68). In terms of HLA-mismatch, UCB-HSCs have less 
rejection, leading also to less graft-versus-host-disease (GVHD) and the possibility of using a 
wider-range of donors for transplantation (69). Finally, UCB-HSCs have a higher 
differentiation potential than BMw-HSCs, which is also extremely important for 
transplantation (70). Altogether this knowledge about cells derived from UCB lead to 
conclude that this source seems to be the safest and the best for tissue engineering. It is also 
important to emphasize that UCB is many times discarded as a biological waste in hospitals, 
although this has been decreasing due to the creation of private and public UCB banks. 
 
 
3. Coculture of ECs with supportive cells 
 
As it was discussed above, capillaries are formed by an endothelium composed of tightly 
connected ECs that is the immediate structure to contact with blood elements. However, this 
tube is covered with a specific matrix, and more importantly, by mural cells that play active 
roles in the capillaries and vessels dynamics and are now known to have a crucial role in 
angiogenesis (71-72). 
In the microvasculature, PCs are the major mural cells found in capillaries, while SMCs are 
found in precapillary arterioles. Although ECs migrate and make sprouts without mural cells’ 
help during angiogenesis, PCs are among the first cells responsible for the invasion of newly 
vascularized tissues and appear located at the growing front of the endothelial sprouts. They 
determine the location of sprout formation and guide newly formed vessels by interaction 
with EC via paracrine communication (72-73). Actually, PCs have a close molecular 
interaction with ECs. Betsholtz et al (74) described ECs as producers of platelet derived 
growth factor – B (PDGF-B) and PCs as expressing PDGF receptor-β (PDGFR-β). PDGF-B recruits 
PCs from the surroundings of the sprouting vessel to participate in angiogenesis. This process 
is also accomplished by vascular endothelial growth factor (VEGF) released upon hypoxia, that 
not only stimulates ECs to proliferate and migrate, but also directly induces proliferation and 
migration of PCs (72, 75). Other interactions between ligands and their receptors are also 
responsible for the tight relation between PCs and ECs. NG2 and Notch-3 system and Ephrins 
(Eph) and Eph receptors system are also responsible for endothelial cell motility, mural cell 
migration, spreading and adhesion during vessel wall assembly, and PCs and ECs assembly 
(72). Thus, it is clear that mural cells, in this case PCs, have a crucial role in vessel 
organization and stabilization. Moreover, these cells act in angiogenesis and in vessel 
remodeling processes showing the importance of mural cells for neovascularization strategies. 
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In fact, the latest research performed in terms of neovascularization strategies, uses the 
recent findings regarding the crosstalk between supportive/mural cells and ECs, to create 
more functional vascularized systems. The interaction of mural cells with ECs has been the 
subject of study of many research teams. When cultured alone, ECs proliferate and grow until 
confluence, establishing cell-to-cell contacts and forming a monolayer. If these cells are not 
passaged, they detach, remaining in suspension and ultimately die. This phenomenon does 
not resemble the tubular-like structures found in vessels in vivo, which are barely seen and 
highly unstable in 2D culture systems, and even in 3D cultures (76-82). However, when ECs 
are cocultured with supportive cells such as fibroblasts, MSCs, PCs or SMCs, their organization 
is achieved and tubular-like structures are formed that resemble the normal ECs alignment 
(76-82). 
Recent findings about phenotypic characterization of PCs and perivascular cells (PVCs) have 
led to a great discussion whether these cells are MSCs. Crisan et al (83) and Corselli et al (84) 
showed that PVCs and PCs that reside in the outmost layer of blood vessels are the in vivo 
counterparts of MSCs (71). Regardless where these cells are isolated in the human body, they 
all express MSCs phenotypic markers and present multipotency, having the ability to 
differentiate into various mesenchymal lineages, including the osteogenic, chondrogenic, and 
adipogenic. Moreover, when cultured in vitro and stimulated with angiogenic factors (e.g. 
when cultured in EGM2), adventitial MSCs acquire a pericytic-like phenotype (84), which 
suggests that these cells upon a proper signaling by angiogenic factors (or under a hypoxia 
situations), adopt a pericytic-like phenotype to differentiate into PCs that need to be 
recruited for the angiogenesis process. 
Indeed, many studies have explored the potential of MSCs as mural cells for ECs survival, 
angiogenesis enhancement, and neovascularization (77-80, 85-87). Carrion et al (77) 
described the role of α6 integrin subunit in MSC-mediated angiogenesis. When this molecule 
was knockdown, capillary sprouting of ECs was significantly reduced, causing the failure of 
MSCs to associate with the nascent vessels (77). A distinct property that defines MSCs is their 
ability to produce factors that act by a paracrine effect. Aguirre et al (79) described the 
transference of fluorescent dyes between MSCs and EPCs in coculture, probably by vesicles 
transport. Initially, cells were dyed with two different lipophilic ﬂuorescent dyes, and over 
time cells with two dyes were increasingly detected suggesting a vesicle transport 
phenomena. Indeed, the transfer of cellular material has been recently described by Liu et al 
(88). MSCs were added to HUVECs that suffered oxygen deprivation and reoxygenation. This 
anoxia suffered by HUVECs has led MSCs to transfer mitochondria to HUVECs by tunneling 
nanotubes in order to rescue HUVECs from oxygen deprivation. This data emphasizes the 
crucial role that mural cells play in enhancing ECs survival and can explain why MSCs, when 
injected in schemia situations improve blood reperfusion. Moreover, not only MSCs secrete 
key cytokines and growth factors that will affect ECs in a paracrine way, but they also 
produce a vast number of matrix proteins that participate in the assembly of a new ECM at 
the wounded tissue and serve as cues for them and for other cells (89). The molecular 
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signaling from this new matrix is essential for ECs survival, as the endothelium organization is 
highly dependent on the ECM surrounding it, as discussed above. In fact, our group has also 
reported that MSCs in 3D are able to produce a complex fibronectin (Fn) mesh (90), an 
essential ECM protein that serves as an important cue for correct ECs anchorage and 
alignment. A very good review of the data regarding MSCs and ECs cross-talk and MSC 
angiogenesis promotion can be read for further information (91). 
 
 
4. Three-dimensional cultures of ECs 
 
4.1. Three-dimensional hydrogel-cultures 
 
In 1983, Montesano et al (92) have shown the importance of a 3D environment for ECs. Bovine 
ECs were cultured on top of collagen gels for 3 days and the results presented suggest that 
these cells displayed a behavior similar to that observed in a 2D environment, showing some 
interaction, forming a few agglomerates but without the formation of tubular-like structures. 
However, when covered with another layer of collagen on top, i.e. in a real 3D environment, 
cells started to form interconnecting cords of cells, resembling what happens in vivo. 
In fact, there are several aspects of the cell microenvironment that 2D systems fail to mimic. 
These differences were first described in a study by Elsdale and Bard (93), where fibroblasts 
were cultured within a 3D structure composed of collagen type I. Under such conditions, but 
not in 2D, these cells were able to create a 3D organization that partially mimicked 
connective tissue cells in vivo. Since then, several studies on the behavior of 3D cultured cells 
have been performed (94-99). 
Nowadays, it seems clear that 3D cell cultures are essential models for the study of cell 
biology, as they can incorporate mechanical and biochemical stimuli directly conveyed by the 
matrix. In fact, it is now evident that in order to harmoniously create a tissue, cells must 
interact not only with each other but also with their ECM (94-99).    
Thus, to culture cells under “real” 3D conditions, i.e. entrapped, it is necessary to use as 
culture substrate a material that can mimic the ECM, and recapitulate some key aspects of 
the native cellular microenvironment. 
Taking this in consideration, an optimal material should provide a high content of water and 
good permeability in order to facilitate the diffusion of oxygen and transport of nutrients and 
other soluble factors throughout the matrix, reaching all the cells within it, and at the same 
time allowing the outward diffusion of cellular metabolites. Hydrogels are very interesting 
materials for this kind of application, as they exhibit all these essential properties. Among 
them, some types of hydrogels are intrinsically “inert”, but can be specifically functionalized 
with key bioactive moieties (100-102). 
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4.2. ECs cultured within 3D hydrogel matrices 
 
As it was discussed before, there are several cell processes that cannot be recapitulated in 2D 
cultures. Angiogenesis is a process highly dependent on the surrounding microenvironment, as 
ECs must concomitantly establish integrin-mediated adhesive interactions with matrix-bound 
ligands. These adhesive interactions are important for the subsequent shape changes that will 
activate actomyosin-dependent contractile responses (103). Motogenic, proliferative, and 
morphogenic programs are all triggered by the tight relation between matrix and cells, and 
neovascularization only occurs with the interplay of all these actors (103). Thus, the 3D 
microenvironment has great importance for the correct ECs behavior. For tissue engineering 
this knowledge is extremely important. In order to have a system that can generate new 
vessels in vitro, or in an in vivo implantation, a 3D culture system is mandatory. 
The work of Zhou et al (103) shows the importance of ECM and 3D environment. Indeed, ECs 
when cultured in 3D conditions were able to initiate neovascularization by unfolding soluble 
Fn and depositing a pericellular network of fibrils. This network served to support 
cytoskeletal organization, actomyosin-dependent tension, and the viscoelastic properties of 
the embedded cells in a 3D-specific fashion. The same process was not accomplished by cells 
in 2D conditions, as these cells are unable to produce a pericellular network of fibrils leading 
to a lack of cytoskeletal organization that ultimately leads ECs to sense the environment 
differently, not being able to undergo apoptosis and senescence because of the ECM signaling 
is not interpreted correctly by cells (103). 
The ECM also influences ECs behavior through physical signaling. Changing the mechanical 
properties of ECM has great impact on cells, and for ECs the impact is crucial for the 
formation or the absence of tubular-like structures (104). Urech et al (104) observed that 
when fibrin ECM was stiffer, the cells were not able to form tubular-like structures, despite 
remaining viable. This result reflects the physical input that ECM has on ECs when cultured in 
a 3D environment. Indeed, the exogenous and endogenous forces are critical regulators of 
endothelial cell health and blood vessel maintenance (105). These forces can only be 
correctly mimicked if cells are surrounded by a 3D matrix as it was demonstrated in the above 
examples. For tissue engineering therapeutic purposes, the understanding of biochemical and 
biophysical cues that regulate ECs behavior, and their respective assembling for formation of 
a functional endothelium, is mandatory for a system capable of neovascularization usable in 
clinical practice. 
Hydrogels matrices are often used to culture ECs under 3D conditions. Collagen gels (106-
108), purified fibrin (108-110), Matrigel (111), or a mixture of these proteins with others, are 
among the hydrogels most commonly used. As mechanical properties can be tuned to some 
extent in hydrogels, these 3D systems can be easily optimized to culture ECs. Not only these 
properties can be changed by crosslink extent of the polymer or the polymer content itself, 
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but hydrogels are also permissive to mechanical changing through the embedded cells (90, 
112). These properties can be tuned to favor ECs organization into tubular structures, often 
with lumens, that can be quantified and monitored in real time by videomicroscopy, as 
hydrogels can be monitored by a confocal microscope (113). 
Another material that has been used for ECs culture is alginate (114-117). Alginate is a 
naturally derived polysaccharide, composed of (1-4)-linked β-D-mannuronic acid (M units) and 
α-L-guluronic acid (G units) monomers, varying in amount and sequential distribution along 
the polymer chain. The alginate molecule is a block copolymer of GG, GM and MM sequences. 
Divalent cations such as Ca2+ bind the GG regions of adjacent alginate chains, resulting in 
ionic crosslinking, and the formation of a hydrogel from aqueous alginate solutions. 
Crosslinking may be promoted in situ, under mild conditions, and a variety of techniques can 
be used to control gelling and mechanical properties of the resulting hydrogels (118). In order 
to have a cell-interactive hydrogel, alginate can be chemically modified with the peptide 
sequence RGD (119-123), an adhesion motif present in several ECM molecules that interacts 
with adhesion molecules present at the cell’s surface. This kind of functionalization provides 
an integrin-mediated interaction between the ECM mimic and the cells entrapped within it 
(120). 
In particular, our group has been studying how HUVECs behave in a 3D RGD-alginate hydrogel. 
Bidarra et al (124) showed that ECs were able to proliferate and maintained 80% of viability 
for at least 48 h, after being embedded. ECs were also able to organize into 3D cellular 
networks inside the hydrogel and, when in contact with matrigel, cells migrated out of the 
hydrogel forming tubular-like structures (Figure 2). Thus, this work shows that alginate 
hydrogels can be used as an adequate substrate to culture ECs in a 3D fashion, and be used 
not only for mechanistic in vitro studies, but also as an ECs delivery system. 
 
 
Figure 2 – Representative phase-contrast micrographs of HUVECs. Cells have migrated out from the 
alginate matrix into the surrounding tissue mimic (Matrigel), where they formed tubular-like structures. 
Images at different magnifications were taken after 24h of incubation (adapted from (124)).  
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5. Cell-in-gel 3D microarrays 
 
Understanding the mechanisms of microenvironmental cellular regulation in 3D, which include 
not only the effect of soluble factors and cell–cell interactions, but also cell-matrix 
interactions, is quite challenging (125). In order to capture a more global picture of extrinsic 
control of cells fate, it is necessary to systematically deconstruct the role of each of these 
signals and their interplay, which is very time-consuming. Moreover, for this kind of set-up, 
huge amounts of materials and cells are needed, which greatly increases the cost of the 
experiments. One possible solution to these issues is the use of HTS platforms. Essentially, 
the aim is to miniaturize the experimental set-up to allow the concomitant parallelization of 
different trial conditions, ideally on a single microscope slide (126).  HTS can then be used to 
scan the influence of various physical, chemical, and biological properties on the cellular 
behavior (127). Instead of individually test each parameter, these approaches aim to take 
information from the complexity of biological systems through combinations of various 
parameters (127). 
Up to know, a few microarray platforms for HTS of cell behavior have been developed. For 
example, Flaim et al (128) have used these platforms for screening the effects of ECM 
proteins in stem cell differentiation. Other authors have used similar methods to analyze the 
influence of growth factors (129) and biomaterials (130) on stem cell growth and 
differentiation in a high-throughput (HT) manner. However, the majority of the “cellular 
microarrays” that have been described in the literature are in 2D (“cell-on-gel”). In order to 
add the 3rd dimension to such assays, “cell-in-gel” microarray formats have to be created. 
Only a few groups have attempted to do that in a HT set-up. For example, Fernandes et al 
used microarray-spotting techniques to deposit nanodrops of cell-laden alginate solutions 
(131-133). Although the authors were able to take an important step towards HT screening, 
they have mainly achieved the patterning of multiple, repeated samples in an array, without 
combinatorial complexity, which still remains a major challenge in the field. (90) Recently, 
Dolatshahi-Pirouz et al (134) described a robotic microarray spotter capable of printing 
different hydrogel formulations with hMSCs embedded within methacrylated gelatin 
hydrogels. The authors used this platform to combine different ECM compositions with 
different media in order to evaluate the best condition that enhances the expression of 
osteogenic markers. This work represented an important advance in the HTS for studying cell-
ECM communication in 3D. It showed that a rather simple technique can be used to study how 
hMSC interact with important ECM proteins, making it possible to screen 96 different 
combinations in only one assay. With such a tool, it is possible not only to reduce the material 
needed to perform an experiment, but also the time spent in defining the best possible 
condition (134). 
Advances in bioprinting technologies have been crucial to develop this type of systems. 
Bioprinting is defined as the use of printing technology to deposit living cells, ECM 
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components, biochemical factors, proteins, drugs, and biomaterials on a receiving solid or gel 
substrate or liquid reservoir (135). 
In comparison to other patterning methods, bioprinting presents some advantages as a 
technique to produce cellular microarrays. First of all it is simple to use and works with 
several systems previously optimized for other purposes. Since these technologies are 
relatively simple, the process to obtain geometrically well-defined patterns with polymers or 
ceramics is inexpensive and rapid (136), leading to HT deposition of ECM analogues (137). 
Last, but not least, also being a revolutionary technology, bioprinting provides 3D complexity 
by multi-layer printing (137-139). There are several possible methods that can be used for 
this type of bioprinting. Acoustic (140-141), inkjet (142-143), valve-based (139, 144-146), and 
laser printing technologies (147-150) are the most commonly used ones (Figure 3). 
 
 
Figure 3 – Sketch of bioprinting technologies. (a) Thermal and piezoelectric ink-jet printing. Two 
major methods to jet the bio-ink are demonstrated. (b) Setup for acoustic pico-liter droplet generation. 
Droplets can be deposited drop-on-demand with predetermined separation and locations. (c) Sketch of 
the valve- based printing setup. (d) Sketch of the laser printing setup. (Left) Laser-guided direct cell 
printing. (Right) (adapted from (135)). 
 
The first approach to construct a bioprinter actually came from the common concept of a 
printer. Wilson and Boland (151) have reported how they modified a common HP printer to 
start to print biomolecules and cells. Since this pioneer idea, a lot of efforts have been made 
for improving all the technologies involved in the bioprinting field. Following this idea of an 
inkjet system, some authors have used this technology to place a cell suspension in a 
cartridge connected to a computer, allowing the controlled printing of the cell suspension in 
the substrate, creating a controlled pattern (142-143). This method has a good throughput, 
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since it can print very fast, but unfortunately lacks of single cell control and spatial resolution 
(Table 3). 
  
Table 3 – Comparison of commonly used bioprinting technologies based on performance (adapted from 
(135)) 
 
 
Another method to print cell-in gel constructs is the valve-based droplet ejection method 
(144-145). The hydrogel droplets are ejected onto a surface, in a drop-on-demand fashion, 
allowing the control of the number of cells printed per droplet and also the number of 
droplets wanted to be printed. However, in this case the printable droplet sizes are too large 
for a developing microarray platforms and the throughput is not so high. In order to have a 
precise spatial resolution with a cell printing controlled at the unit level, laser-guided direct 
printing is the best option leading to constructs very well spatial organized. This technique 
uses the power of photons from a laser beam to trap and guide cells by exploiting the 
differences in refractive indexes of cells and cell media (147). The spatial resolution is so high 
that this technique is being used for the construction of 3D cell structures like vascular 
structures composed of HUVECs printed in parallel layers of matrigel (152), and also the 
micropatterning of liver sinusoid-like structures with micrometer resolution in vitro (147). 
Despite the great advantages of this technique its throughput is very low. An alternative to 
this, that combines HT and high single cell control, is the acoustic bioprinting. Via acoustics 
this technique is capable of printing 100 000 droplets per second (140) and make well-defined 
patterns. Also, this technique is not harmful to the cells, since the wave’s energy does not 
affect cell viability. Regarding the spatial range, it can goes from 10 to 500 μm which enables 
a great variety of different formulations (Further reading:  Tasoglu and Demirci review (135)). 
The last technique referred in this brief description is the laser-induced biopriting (Figure 4). 
This was the bioprinting technique explored in this work, and it is therefore described in more 
detail. 
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Figure 4 – Laser-assisted bioprinting, featuring all the parameters involved in the process (adapted 
from (153)). 
 
Laser-assisted or laser-induced bioprinting is usually composed of three elements: a pulsed 
laser source, a target coated with the material to be printed (the ribbon) and a receiving 
substrate (Figure 4) (153). The ribbon is a multilayer component (Figure 5) that has a 
support transparent to laser radiation wavelength and a layer that is going to be transferred – 
bioink. This layer will transport the biomolecules, cells or biomaterials so it has to be 
sensitive to the heat caused by the laser beam.  
 
 
Figure 5 – Laser-assisted Biopriting composition. 
 
As schematized in Figure 5, there is the need to use a laser-absorbing interlayer, since 
sometimes the bioink itself is not transferable by the laser energy. This layer is going to 
absorb the energy and induce the transfer of the bioink. Hence, this technique is also called 
matrix-assisted pulse laser evaporation- direct write (MAPLE-DW) (154). This interlayer that is 
first vaporized eliminates direct interaction between the laser beam and the bioink. Usually 
this layer consists of a thin film (tens of nm) of metal (Au, Ti, Ag), metal oxide (TiO2) or 
photo-decomposing volatile polymer (triazene) (153). 
Support: Glass
Support laser-absorbing interlayer:
Gold
BioInk
Pulsed laser source
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This technique – LAB – appears has an attractive alternative to inkjet and micro-pen printing 
devices. In fact, these other techniques present some problems like the clogging (due to the 
viscosity, cell agglomeration, ink drying or even gelation) of the printing heads or capillaries 
used by these printers to achieve micron-scale resolution. Also, comparing to the laser-guided 
bioprinting referred above, LAB is capable of making the rapid deposit of material at a rate of 
kHz and works with mild-viscous solutions (153). 
The printing process used in LAB is schematized in Figure 6. Briefly, a pulsed (typically 1-20 
μJ per pulse) ultra-violet (UV) or infra-red (IR) Laser will cross the transparent material 
(frequently glass) (Figure 6.1). The interlayer composed of gold will absorb the laser’s energy 
and starts to evaporate (including normal boiling and phase explosion) forming a plasma that 
may further form a vapor bubble that expands towards the free surface (Figure 6.2).  
 
 
Figure 6 – Step-by-step mechanism of laser-assisted bioprinting. 
 
The bubble collapses due to a high-pressure region generated in the bubble apex and a jet 
may be formed (Figure 6.3). This jet advances at a constant velocity (20–150 m/s, depending 
on experimental conditions) until it reaches the receptor substrate leading to material 
deposition (Figure 6.4). Depending of the landing, the jet conditions and, most importantly, 
the surface properties, the formation of little droplets in the range of pico-to-nano liters, 
occurs in an HT manner (Figure 6.5) (153). 
As it is possible to see in Figure 6, there are a large number of conditions that may affect all 
the process.  These conditions are yet to be all decoded and a lot of effort has been done by 
„1. Laser energy deposit (1 J/cm²) 2. Vapor bubble growth & collapsing (1 μs)
„3. Interaction of the vapor bubble with 
the free surface
4. Jetting (50 m/s)
5. Deposit: landing
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Guillemot’s team at INSERM to unravel the influence of several parameters in the bioprinting. 
In this work, we tried to correlate some of these conditions with the printing outcome. 
Duocastella et al (155) have been studying the influence of viscosity and surface tension in 
the LAB performance. It appears that when the viscosity of the bioink solutions is increased, 
the energy input necessary for the bubble formation has to be higher. This means that all the 
process is not only related to the laser beam power, but also with the rheological properties 
of the bioink (153, 156).  
Other important aspects that can influence the printing are surface properties. The gap 
between the bioink and the susbtrate was shown to be finite, since the jet has to reach the 
surface of the susbtrate (155). 
 
 
Figure 7 – Laser-induced droplet ejection regimes (adapted from (153)). 
 
Also the wettability and possible coating of the surface will not only affect the jet deposit by 
physicochemical affinity, but also the formation of proper droplets that can be used for cell 
culture and microarrays production. For instance, a more hydrophilic surface is going to have 
an impact in the droplets diameters and heights, since hydrogels tend to spread more in this 
kind of surfaces. Also in terms of stability overtime, the hydrogel droplets of the microarray 
have to persist adhered to the substrate surface. These and other parameters are going to be 
discussed further in this work (153). 
The parameters involving the ribbon, the bioink, and the laser beam are very important to 
control. As it was described above, these parameters will ultimately affect the laser dynamics 
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affecting the laser regime (Figure 7). There are three possible regimes: sub-threshold 
regime, jetting regime, and plume regime. For a certain viscosity and film thickness, the 
jetting regime is observed only for intermediary laser fluencies. For lower fluencies, the 
bubble collapses far from the free surface without generating a jet. The opposite behaviour 
occurs for high fluencies. In this case the bubble bursts to the surface, generating sub-
micrometer droplets. These correlations between film thickness and bioink viscosities force 
the operator to optimize all the bioprinting parameters for a certain bioink (153, 156). 
Recently, LAB is being used for several tissue engineering applications, namely for 3D tissue 
formation and organization (157); for the study of the molecular mechanisms involved in stem 
cell fate and commitment (131); to print engineered tissue substitutes directly into in vivo 
models (158); to allow robotic-assisted medical intervention (159), and to create in vitro 
models for the characterization of cell-environment effects (160-161). 
However, until now, there are no studies that have fully addressed the potential of LAB as a 
technique to develop microarray systems in 3D. Moreover, no attempts have been made to 
make complex studies combining such strategies with the use advanced artificial ECMs with 
tunable biochemical and mechanical properties. In the present work, we intended take a first 
step towards that end. In brief, we have tried to combine the advantages of using the tunable 
ECM-like 3D matrices, developed by our team (120, 124, 162) with LAB, for the creation of a 
cell-in-gel 3D microarray platform. To produce the microarrays, bioinks with different 
polymer concentrations (1% and 2% w/v alginate) and different cellular densities were used to 
study the impact of these parameters in the bioprinting process and on cells behavior. 
Another innovation tested here was the use of self-gelling bioinks, composed of alginate and 
cells combined with gelation agents (CaCO3 and GDL). This allows the printing process to be 
made in just one step, with the gelation of the droplets occurring slowly after the spotting 
has been made. In particular, in this work we wanted to establish whether LAB could be use 
to: (a) print bioinks with different cell densities and variable viscosities; (b) obtain a 
controlled cell patterning (equidistant and regular micro-spots); (c) maintain cell viability 
along the printing procedure; (d) produce microarrays that remained stably attached to the 
receiving substrate along the subsequent period of culture. Next we wanted to validate the 
microarray culture (cell-in-gel micro-spots) by comparing some of the obtained results with 
those obtained using a MT assay (cell-in-gel disks), previously established in our team. The 
final goal was to use this new HTS platform for the analysis of EC-MSC crosstalk in 3D. 
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1. Isolation and characterization of UCB cells A and UCB cells B  
 
1.1. Isolation of EPCs and OECs from UCB samples 
 
UCB samples were collected during labor at Hospital São João. All of the donors signed an 
informed consent form that is in compliance with the Portuguese legislation and the ethical 
committee of the referred hospital, approving the collection. After collection, the samples 
were stored and transported in 250 mL sterile bags that contained 35 mL of CPDA‐1 (Citrate, 
Phosphate, Dextrose and Adenine) anti-coagulant solution (Mollitia). MNCs were isolated from 
blood using Ficoll (Histopaque‐1077 Hybri Max; Sigma‐Aldrich) density gradient separation 
(Figure 8) as previously described (163). Briefly, blood samples were diluted 1:1 with Hank’s 
Balanced Salt Solution (HBSS, Alfagene) and gently dropped on top of 20 mL of Histopaque® 
solution. 
To obtain OECs, centrifugation was performed at 780 x g for 30 min. Mononucleated Cells 
(MNCs) rings were then transferred onto 50 mL Falcon tubes, washed with twice their volume 
of HBSS and afterwards resuspended in supplemented Microvascular Endothelial Cell Growth 
Medium-2 (EGM2-MV, Lonza), with 10% FBS. Cells were plated onto collagen type-I–treated 
plates (Enzifarma) at a cellular density of approximately 1x106 cells/cm2 and cultured for 18-
21 days at 37ºC, in a humidified atmosphere with 5% v/v CO2 in air, with medium change 
every day, until the formation of colonies. Cells were then detached by tripsinization (0.25% 
w/v trypsin/ethylenediamine tetraacetic acid (EDTA) solution, Sigma), cultured in uncoated 
6-well plates with EGM2-MV. When confluent, cells were either frozen or expanded until 
passage 3, when they were used. These cells will be hereafter designated as UCB Cells A. 
To obtain EPCs, centrifugation was performed at 400 x g for 30 minutes. MNCs rings were then 
pipetted onto 50 mL tubes, washed with twice their volume of HBSS and afterwards 
resuspended in supplemented EGM2-MV, with 10% FBS and without hydrocortisone 
supplement. Cells were plated onto Fn-treated plates (normal plates were incubated for 30 
min with Fn solution (Enzifarma) at 1 mg/mL and let dry at room temperature (RT)) at a 
cellular density of about 1x106 cells/cm2 and then cultured for 5 days at 37ºC, in a humidified 
atmosphere with 5% v/v CO2 in air, without medium change. After tripsinization, cells were 
immediately used for experiments. These cells will be hereafter designated as UCB Cells B. 
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Figure 8 – Protocol isolation for er-EPCs and OECs.  
 
1.2. Fluorescence-activated cell sorting analysis (FACS) of UCB cells A and 
UCB cells B 
 
After tripsinization (0.25%), both UBC cells A and B were aliquoted (105 cells per condition), 
centrifuged, and resupended in FACS buffer (PBS; 0.5% w/v bovine serum albumin; 0.01% w/v 
azide, Sigma-Aldrich). After being washed twice, cells were incubated for 30 minutes at 4ºC 
with isotype controls (Mouse IgG1 FITC and Mouse IgG1 R‐PE; both from Caltag Medsystems), 
or antigen‐specific mouse anti‐human antibodies: CD31‐APC (Myltenyi Biotec), CD34‐FITC, 
(Caltag Medsystems), CD45-FITC (Imunno Tolls), and CD14-APC (Imunno Tolls). A control with 
non-stained cells was also performed. After incubation, all samples were centrifuged and 
washed twice and markers expression analysis was carried out by three-color flow cytometry 
on a FACSCalibur flow cytometer (BD Biosciences). Data analysis was made using FlowJo® 
software.  
  
400x g 780x g
Fibronectin coated plates Collagen type I coated
plates
Ficoll®
Blood:HBSS
1:1
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1.3. Immunofluorescence analysis of expression of ECs markers in UCB cells A 
and B 
 
Immunofluorescence staining was performed to assess the expression of ECs markers. Both 
UCB cells A and B were fixed with 4% v/v paraformaldehyde (PFA; Merck Millipore, Darmstadt, 
Germany) for 30 min at RT, washed with PBS, and permeabilized with 0.2% v/v Triton X-100 
(Sigma-Aldrich) in PBS for 10 min. For VE-cad analysis, samples were incubated for 10 min in 
ammonium chloride (50 mM NH4Cl, Sigma-Aldrich) before permeabilization. After washing 
with PBS, the samples were incubated for 1 h at room temperature in blocking solution (4% 
v/v FBS in 1% w/v BSA in PBS) and incubated overnight at 4ºC with the following primary 
anti‐human antibodies: monoclonal mouse CD31 (PECAM1; Dako, 1:50), monoclonal mouse VE-
cad (VE-cad; Santa Cruz Biotechnology, 1:100), and polyclonal rabbit vWF (Dako, 1:300). 
Excess antibody was removed by washing with PBS and samples were incubated with the 
secondary antibodies (Alexa Fluor® 594 anti-mouse, Alexa Fluor® 488 anti-rabbit, Alexa 
Fluor® 488, and Alexa Fluor® 647, Invitrogen, 1:1000) for 1 h at RT. The nuclei of cells was 
stained with 4',6-diamidino-2-phenylindole (FluoroShield™ with DAPI; Sigma-Aldrich). Negative 
controls were also performed with only secondary antibody staining to validate the assay. 
Samples were visualized under a Zeiss inverted fluorescence microscope (IFM, Zeiss Axiovert 
200, Carl Zeiss International) and the resulting images were processed using Fiji Imaging 
Software. 
 
1.4. Endothelial functional assay 
 
 
Samples were incubated with 10 μg/mL of DiI-labeled ac-LDL (Bioquote) for 4 h at 37ºC and 
washed three times with EGM2 or EGM2-MV. The uptake of Ac-LDL was visualized under an 
inverted fluorescence microscope. 
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2. Establishment of hydrogel-based 3D cultures 
 
2.1. Cell cultures 
 
HUVECs and MSCs (Lonza) were routinely kept in culture at 37ºC in a humidified atmosphere 
with 5% v/v CO2 in air. Media was changed every two days: HUVECs were cultured in complete 
M199 (Sigma-Aldrich) with 10% v/v FBS, 0.1 mg/mL Heparin (Heparin Sodium Salt; Sigma-
Aldrich), 1% v/v Pen/Strep. Endothelial Cell Growth Supplement (ECGS; BD Biosciences) at a 
concentration of 3 μL/mL was added every time the media was changed. MSCs were cultured 
in Dulbecco’s Modified Eagle medium (DMEM; Invitrogen) with 10% FBS and 1% P/S. Both 
HUVECs and MSCs were trypsinized when they reached confluence. For the following 
experiments, cells from passages 6 and 7 were used. Regarding UCB cells A and B, isolation 
was made according to the method described in Section 1.1. and there was no incubation 
period prior to cell embedment. 
 
2.2. Preparation of peptide-grafted alginate 
 
Ultra pure alginate with high content of guluronic vs mannuronic acid units (>60%, 
NovaMatrix, FMC Biopolymers) and different molecular weights were used. High molecular 
weight alginate (HMW; 150 kDa) was oxidized and modified as previously described (164). The 
cell-adhesion peptide sequence (glycine)4-arginine-glycine-aspartic acid-serineproline 
(G4RGDSP, GenScript), hereafter abbreviated as RGD, was coupled to oxidized High Molecular 
Weight (HMW) alginate using carbodiimide chemistry, as described in detail in previous 
studies (162). Briefly, a 1 % (w/v) alginate solution in 0.1 M MES buffer (Sigma) was prepared 
and stirred overnight Sulfo-NHS (Thermo Scientific) and EDC (Sigma) at 1:2 molar ratio were 
then sequentially added and stirred for 15 min, to activate polymer COOH- groups before 
addition of the RGD peptide (17 mg/g alginate). After stirring for 24 h, the reaction was 
quenched with Hydroxylamine (NH2OH, Sigma). Nonreacted species were separated by dialysis 
(MWCO 3500 membrane, Spectrum Lab) against solutions of decreasing concentration of 
Sodium Cloride (NaCl, Merck) and finally in deionized water. The recovered solution was 
lyophilized and the RGD-alginate was stored at -20ºC until further use. 
2.3. Preparation of RGD-alginate self-gelling hydrogel disks 
 
To prepare in situ crosslinking hydrogel matrices an internal gelation strategy adapted from 
Kuo et al. was used (165-166). The alginate gel precursor solution was a 50:50 v/v binary 
mixture of RGD-grafted oxidized HMW alginate and unmodified Low Molecular Weight (LMW) 
alginate, prepared at a total alginate concentration of 1 an 2% (w/v) in 0.9 wt.% NaCl (Sigma-
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Aldrich). This formulation has been previously optimized by our team (162, 167) with final 
concentration of RGD peptide of 200 μM. The solution was sterile-filtered (0.22 μm) and 
thoroughly mixed with an aqueous suspension of CaCO3 (Fluka) at a CaCO3/COOH molar ratio 
of 1.6. To trigger gel formation, a fresh solution of GDL (Sigma) was added. The CaCO3/GDL 
molar ratio was set at 0.125. The pre-gel solution was then added to the cell suspension with 
the correct number of cells and hydrogel disks (15 μL) were casted between Teflon plates 
with spacers of 700 μm. The cell-laden mixture was left to crosslink for 1 h at 37ºC under a 
humidified atmosphere, and placed in 24 well plates before medium was added. The medium 
was changed 30 min after to stabilize the pH and the final constructs were incubated at 37ºC 
in a humidified atmosphere with 5% v/v CO2.  
For cocultures, either HUVECs or UCB cells A in suspension were mixed (1:1 ratio) with MSCs 
at a final cellular density of 10 million/mL, while in triple-cultures, the same final density 
and ratio between HUVECs and MSCs was maintained, but UCB cells B were also added at a 
final cellular density of 10 million/mL. Controls of monocultures were also performed for 
HUVECs, MSCs, UCB cells A and UCB cells B at a final cellular density of 10 million/mL of gel 
precursor solution. For cocultures of HUVECs and MSCs, cells were maintained in EGM2 
medium during the culture period, while for cocultures of MSCs and UCB cells A, cocultures of 
HUVEC and UCB cells B, and triple-cultures, cells were maintained in EGM2-MV medium. 
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3. Cell behaviour in 3D cell cultures 
 
3.1. Metabolic activity and cellular viability 
 
The metabolic activity of entrapped cells in alginate matrices was assessed by resazurin 
assay. Resazurin (resazurin sodium salt at 0.1 mg/mL; Sigma-Aldrich) was diluted (20% v/v) in 
the respective medium (EGM2 or EGM2-MV) and incubated with the disks for 3 h at 37ºC. A 
fluorometer (Synergy MX; Biotek, Winooski, US) was used to excite the samples at 530 nm and 
read the fluorescence at 590 nm. EGM2 or EGM2-MV with resazurin (20% v/v) were used as 
blank samples. 
Cell viability within alginate disks was determined with a Live/Dead assay. CyTRAK Orange™ 
and DRAQ7™ (both from Biostatus) were used as dyes for live cell and dead cells, respectively. 
CyTRAK Orange™ was diluted in medium at 10 μM as final concentration, while DRAQ7™ was 
diluted in medium at 3 μM as final concentration. Both dyes were incubated for 10 min at RT. 
Disks were then visualized under a laser scanning microscope (CLSM, Leica TCS-SP2 AOBS; 
Leica Microsystems, Wetzlar, Germany). The resulting images were processed using Fiji 
Imaging Software. 
 
3.2. Matrix contraction 
 
After gelification and at day 3, photographs of the disks were taken using a stereoscopic 
microscope (Olympus SZX10). Percentage of contraction was calculated by the difference of 
diameter between day 0 and day 3. Measurement calculations were processed using Fiji 
Imaging Software.  
 
3.3. Cell labelling 
 
Cells were suspended in serum-free medium and labelled with CellTracker™ (Invitrogen) Blue 
(MSCs) or Green (HUVECs) by incubation with 15 μL of the stock solution (prepared according 
to the manufacturer) during 30 min (stirring the solution each 10 min). After centrifugation 
the cells were ressuspended with complete medium and incubated for 30 min. Cells were 
embedded in disks as described in Section 2.3. and disks were then visualized under a laser 
scanning microscope (CLSM, Leica TCS-SP2 AOBS; Leica Microsystems, Wetzlar, Germany). The 
resulting images were processed using Fiji Imaging Software. 
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3.4. Immunocytochemistry 
 
Ac-LDL uptake was used to assess ECs rearrangement and functionality in 3D (as described in 
Section 1.4.). For visualization, disks were washed twice with a solution of TBS 1x/7.5 mM 
CaCl2 and fixed in 4% PFA in TBS/CaCl2. 
Immunocytochemistry of 3D constructs was performed by fixing with 4% v/v PFA in TBS/CaCl2 
for 30 min at room temperature, disks were then washed with TBS/CaCl2 and permeabilized 
with 0.2% v/v Triton X-100 (Sigma‐Aldrich) in TBS/CaCl2 for 10 min. For VE-cadherin analysis, 
samples were incubated for 10 min in ammonium chloride (50 mM NH4Cl, Sigma-Aldrich) 
before permeabilization. The samples were then incubated for 1 h at room temperature in 
blocking solution (4% v/v FBS in 1% w/v BSA in TBS/CaCl2) and left overnight at 4ºC with 
primary antibodies. Excess antibody was removed by washing with TBS/CaCl2. The secondary 
antibodies and phalloidin (Alexa Fluor®-488 Phalloidin; Invitrogen) (when the case) were 
incubated for 1 h at room temperature. Samples were counterstained with DAPI and 
visualized under a CLSM and the resulting images were handled using Fiji Imaging Software. 
Primary antibodies against mouse α-SMA (Dako, 1:100), mouse VE-cad (1:50), rabbit vWF 
(1:150), mouse CD31 (1:50), and mouse CD45 (1:100) were used and detected with secondary 
antibodies referred in Section 1.3. 
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4. Establishment of cell-in gel 3D microarrays: bioprinting 
setting 
 
4.1. Preparation of RGD-alginate bioinks 
 
Bioinks with 1 % (w/v) or 2 % (w/v) alginate in 0.9 wt.% NaCl were prepared and combined or 
not with cross-linking agents and cells (MSCs or HUVECs), as described in Section 2.3. In some 
assays (at INSERM), a MSCs cell line (D1) expressing Tomato protein was used (see section 
2.5.1.) Figure 9 illustrates how the bioinks are prepared and applied onto the receiver 
substrate. 
 
 
Figure 9 – Printing optimization strategy. (1) Printing of alginate only; (2) printing of alginate with 
gelation agents; (3) printing of alginate with gelation agents and cells at different cell densities. 
 
4.2. Bioink rheological characterization 
 
The viscosities of the alginate solutions (1 % (w/v) and 2 % (w/v), with two different cell 
densities - 2 x 106 cells/mL or 15 x 106 cells/mL) were determined with a Kinexus Pro 
rheometer (Malvern Instruments, Malvern, UK), using cone and plate (40 mm cone diameter, 
1° cone angle). The sample solutions were prepared in a similar way as for cell entrapment 
CaCO3 (Ca2+ source)
+ 
Glucone-D-Lactone 
RGD-Alginate 1% or 2% 
HLMW (w/v)  
Donor (gold)
CaCO3 (Ca2+ source)
+ 
Glucone-D-Lactone 
Donor (gold)
Cell suspension
(D1 cells*)
+
Donor (gold)
21
3
Cell Densities 
d1 2 × 106𝑐𝑒𝑙𝑙𝑠/𝑚𝐿 
d2 15 × 106𝑐𝑒𝑙𝑙𝑠/𝑚𝐿 
 
*D1 cells:  express Tomato protein
RGD-Alginate 1% or 2% 
HLMW (w/v)  
RGD-Alginate 1% or 2% 
HLMW (w/v)  
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studies but without the addition of GDL as no gelation triggering should occur. 150 μl of 
sample solution were used for each measurement and the plate was lowered to a measuring 
gap size of 0.015 mm. The temperature was set to 25°C to simulate the temperature at which 
the alginate drops are printed. The evaporation was prevented using a water ring around (but 
not contacting) the sample. The temperature was maintained and the evaporation was 
prevented by the rheometer active hood. The shear viscosity was recorded by applying a 
shear rate ramp from 0.01 to 1000 s-1. 
 
4.3. Bioprinting behavior 
 
Time-resolved imaging (TRI) was used to assess bioink printability. For these experiments the 
bioink with the higher viscosity (2% w/v alginate) was used. A laser energy of 28 Ampere (A) 
and a film thickness of 20 μm were selected. The system used a laser light and a CCD camera 
to take pictures at exact precise times. 
 
4.4. LAB Workstation 
 
The LAB workstation consisted of a solid Nd:YAG crystal laser (Navigator I, Newport Spectra 
Physics) was selected with the following specifications (k = 1064 nm, s = 30 ns, f = 1–100 kHz, 
q = 3.4 mrad, TEM00, ptp < 1.5% rms, P= 7 W). 
A sophisticated five-axe positioning system was integrated into the workstation (NovaLase, 
SA, Canéjan, France) with the purpose of printing multi-color patterns and building 3D 
biostructures. The substrate was held with a (x, y, z) motorized micrometric translation stage 
whose resolution is 1 lm for the (x, y) axis and 5 lm for the z axis. In order to achieve multi-
color printing, a high resolution (1º angular resolution) motorized carousel with a loading 
capacity of five different ribbons was designed (see Figure 10). The substrate positioning 
system and carousel were held on the same vertical axis with the aim of varying focusing 
conditions without changing the gap distance. 
Droplet generation from the ribbon surface was performed by driving the laser beam by 
means of a high speed scanning system composed of two galvanometric mirrors (SCANgine 14, 
ScanLab), with a scanning speed reaching 2000 mm s-1, and a large field optical F-theta lens 
(S4LFT, Sill Optics, France) (F = 58 mm). Focal setting in the ribbon and (x, y, z) substrate 
positioning were carried out via a CCD camera through the optical scanning system.   
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Figure 10 – LAB workstation (a) View of the HT biological laser printer, (b) optomechanical set-up and 
(c) high resolution positioning system placed below the carousel holder with a loading capacity of five 
different ribbons (adapeted from (153)) 
 
The integration of the laser and all above-mentioned components was made possible using 
Solidworks software. Substrate positioning, carousel driving, video observation and pattern 
designs were monitored with dedicated software developed with Delphi software. 
Finally, this CAD/CAM workstation (Figure 10) was placed in a cell culture room in order to 
facilitate cell transfer experiments (9). 
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4.5. Ribbon preparation 
 
As described above, the ribbon is made of three layers: a support, a thin metal absorbing 
layer and a solution of hydrogel. The support is a 30 mm diameter disk made of IR-
transparent quartz. This disk was sputter coated with 20–30 nm of gold using an Emscope 
SC500 coating unit. The thickness was chosen to be higher than the optical skin depth (17 nm) 
at near-IR wavelengths (1064 nm). Then the hydrogel film, composed of a suspension of the 
desired materials, was spread onto the gold-coated quartz disk with a micrometric film blade 
(3570, Elcometer). Typical film thickness was 20 - 30 μm. 
 
4.6. Substrate preparation 
 
Two different substrates (receivers) were used. For printing optimization, the printing 
elements were collected on a quartz disk, whose characteristics were the same as the 
support. For cell culture, microarrays were printed directly into LabTek® (Nunc* Lab-Tek* II 
Chamber Slide* System), which were pre-treated with 0.1% w/v PLL solution (Sigma) for 1h, 
washed 3 time and left to dry overnight. 
 
4.7. Characterization of the transferred materials 
 
Droplets shape, diameters, and cell number per spot counts were measured by contrast 
microscopy and fluorescence microscopy. 
Droplets’ heights were measured by TRI images. Images show a droplet with its reflection. 
Half of the value measured was considered the real height. 
In order to calculate droplets volume, an approximate formula was used (Expression 1). With 
volume values, approximate cellular densities were estimated. 
 
 
 
 
Expression 1 – Calculation used to obtain the approximated droplet’s volume 
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5. Establishment of cell-in gel 3D microarrays:  cell culture 
studies 
 
5.1. Culture of mouse mesenchymal stem cells (D1 cells) 
 
D1 mouse mesenchymal stem cells (D1 cells) (Lonza) expressing tomato protein were 
routinely cultured in a basal medium (hereafter designated as BM) composed of low-glucose 
Dulbecco's Modified Eagle Medium with glutamax (DMEM, Gibco) supplemented with 10% v/v 
Fetal Bovine Serum (Lonza) and 1% v/v Penicillin/Streptomycin (Pen/Strep, Gibco). Cultures 
were maintained at 37ºC under a humidified atmosphere of 5% v/v CO2 in air, with culture 
medium being changed twice a week, and were trypsinized when reaching 70% confluence. 
For some studies, osteogenic differentiaton was induced by culturing cells in induction media 
(freshly made basal medium supplemented with 10 nM dexamethasone (Sigma), 10mM β -
glycerophosphate (Sigma) and 50 μg/mL 2-phospho-L-ascorbic acid (Fluka). HUVECs, routinely 
cultured as described before (Section 2.1.) were also used in some assays. 
 
5.2. Microarrays stability assay 
 
The stability of microarrays bioprinted onto poly-L-lysine (PLL)-treated slides was analyzed. 
Samples were left in basal culture medium under standard culture conditions over one week. 
Contrast microscopy images were taken at day 0, 3, 5 and 7.  
 
5.3. Microarrays cell culture assays 
 
Bioprinted microarrays of 1 % (w/v) and 2 % (w/v) alginate in Superfrost™ and LabTek® slides 
were left in culture for a period of one week under basal or osteogenic conditions. Cell 
viability was analyzed using the Live/Dead Assay (Invitrogen®) according to the manufacturer 
instructions. Osteogenic differentiation was analyzed by alkaline phosphatase (ALP) staining. 
Briefly, slides were washed three times with TBS-Ca (TBS, 50 mM Tris in 150 mM NaCl, pH 7.4 
with 5 mM CaCl2) and fixed with 4% v/v PFA in TBS/CaCl2 for 20 min at RT, followed by 
another washing step, and incubated for 30 min in Naphtol AS-MX phosphate/Fast Violet B salt 
(Sigma) at 37ºC (protected from light). Pictures were taken by confocal microscope (Leica®) 
and fluorescence microscope, and by inverted microscope (Zeiss®), respectively. 
As a comparison test, the bioinks used for each assay were also used for making hydrogel 
microdiscs (MT set-up) and the live/dead assay and ALP staining were also performed as 
described above. 
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5.4. Microarrays coculture printing 
 
Using a 1 % (w/v) alginate solution, microarray cocultures of HUVECs and MSCs were 
established. Both cell types were printed at a final cellular density of 25 million/mL, making 
a total cellular density of 50 million/mL. The two cell types could be distinguished by using a 
combination of fluorescence/bright field microscopy (fluorescence emitted by D1 cells but 
not by HUVECs). 
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Results and Discussion 
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Results and Discussion – Part I – In Vitro 
3D cross-talk between ECs and MSCs 
 
 
1. Isolation and characterization of EPCs from umbilical cord 
blood 
 
 
In this study, we attempted to isolate two different endothelial progenitor cell populations 
from UCB, EPCs and OECs, according to the protocol described by Silva et al (163) (in detail in 
Material and Methods section). MNCs were isolated from whole UCB using a density gradient. 
For OECs isolation, cells were centrifuged at 780 x g and plated on collagen type I-coated 
plates (hereafter designated as UCB Cells A), while for EPCs isolation, cells were centrifuged 
at 400 x g and plated on Fn-coated plates (hereafter designated as UCB cells B). After a 
differentiation period of around 21 days followed by colony isolation and further culture for 
UCB cells A, and 5 days culture for UCB cells B, both cell types were characterized by flow 
cytometry. 
 
As depicted in Figure 11A, UCB cells A presented a single population of cells with some 
diversity of size and complexity. From this data, it is possible to see that UCB cells A did not 
express two of the most common blood lineage markers: CD45 and CD14 (Figure 11B and C). 
CD45 is the pan-marker for blood cells, while CD14 is expressed only by the myeloid lineages, 
which indicates that the isolated cells are not blood cells. The absence of blood markers 
expression was also described by Silva et al (163). CD34, which is a marker for HSCs, has been 
described for some authors to be expressed by OECs (40, 48-49), while other authors describe 
the absence of this marker at the cell membrane of OECs (44, 46). In fact, there is a lot of 
controversy around the expression markers that are characteristic of OECs and for CD34, 
there is no consensus. The authors that describe CD34 expression defend that these cells have 
differentiated from a HSCs ancestral, while the opposite is defended by the other authors. In 
this work, CD34 expression was not detected in UCB cells A, what is in accordance with Silva 
et al (163). Another important feature of OECs is their high mitotic rate. Silva et al (163) 
have described OECs as being highly proliferative cells, with low senescence and high 
telomerase activity. Here, when expanded in 2D culture, UCB cells A seemed to grow rapidly 
and easily in EGM2-MV medium. However, proliferation, and doubling time studies were not 
performed, which will need to be further pursued in the future. Regarding CD31, a 
phenotypic marker characteristic of ECs and highly expressed in mature ECs such as HUVECs, 
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almost all authors describe a wide expression of this marker in OECs (39, 44-49). In particular, 
according to Silva et al (163), the differentiation protocol tested here should have yielded 
CD31 positive cells. 
 
 
 
Figure 11 – Flow cytometry analysis of UCB cells A. (A) Forward and side scatter plot of UCB cells A. 
(B) Histogram analysis for CD34, CD45, CD31, and CD14 expression markers of UCB cells A. UCB cells A 
population in red, while isotype control is in blue. (C) Table with percentages of CD31, CD34, CD45, and 
CD14 expression markers of UCB cells A. 
 
However, here, almost no CD31 expression was found in UCB cells A, with only 3.24% of cells 
being positive for this marker (Figure 11C), which was an unexpected result. 
 
Regarding UCB cells B, their phenotypic profile is completely different. As depicted in Figure 
12, the Forward/Side scatter plot shows two different sub-populations of cells that were 
analyzed separately for their phenotypic markers expression (Figure 12B and 12C). 
Population 1 presented 49.6% of CD31 expression, which is in accordance with other authors 
who describe low expression of CD31 for EPCs populations (39-40).  Despite Silva et al (163) 
have classified EPCs as CD31 positive cells, in his study nothing is said about the percentage 
of positive cells, and this information was only supported by immunocytochemistry. UCB cells 
B from population 1 were also positive for CD45 and CD14, which means that cells came from 
the myeloid lineage. Silva et al (163) also showed that EPCs are CD14 positive, however, in 
his study, nothing is said about their CD45 expression. Yet, CD45 expression by EPCs has been 
described in many different studies, as reviewed by Richardson and Yoder (11). The 
expression profile of UCB cells B suggests that these cells share phenotypic markers from both 
hematopoietic lineage and endothelial lineage. Taking this in account and also that 15.5% of 
the cells expressed CD34, lead us to hypothesize that some cells from this population might 
All cells
CD31+ 3.64 %
CD34+ 0.40 %
CD45+ 0.34 %
CD14+ 0.51 %
A B
CD31
CD45
CD14
CD34
C
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come from a common cell called hemangioblast (13), a cell described on ontology as being 
able to differentiate both in endothelial and blood lineages (37). Another important aspect is 
the difference between populations 1 and 2. Er-EPCs that are the ones yielded upon a short 
period of endothelial differentiation, are described as a heterogeneous cell population. So, 
the presence of two distinct populations as shown in Figure 12A is in accordance with that 
heterogeneity. Here, populations 1 and 2 only differed in their CD34 and CD14 expression. 
Population 2 had lower expression of CD34, which indicates that this population has less 
progenitor features, while CD14 expression indicates that population 2 has less cells derived 
from the myeloid lineage.    
 
 
Figure 12 – Flow cytometry analysis of UCB cells B. (A) Forward and side scatter plot of UCB cells B 
population. (B) Histogram analysis for CD34, CD31, CD45, and CD14 expression markers of UCB cells B. 
UCB cells B population in red, while isotype control is in blue. (C) Table with percentages of 
CD31, CD34, CD45, and C134 expression markers of UCB cells B for all cells, population 1 and 2. 
 
 
The phenotypic profile of MNCs was also analyzed, as a control, to see the shift of the 
phenotypic marks with the differentiation protocol process. All four ligands changed their 
expression in the five days culture of UCB cells B and have a dramatic change in the final 
profile of UCB cells A. CD31, CD34, CD45 and CD14 showed to have expression values of 
UCB cells B
All cells Population 1 Population 2
CD31+ 50.2 % 49.6 % 48.0 %
CD34+ 13.3 % 15.5 % 1.52 %
CD45+ 84.6 % 84.6 % 99.3 %
CD14+ 36.9 % 42.3 % 16.1 %
A
CD45
CD14
Population 1 Population 2All cells
CD34
CD31C
B
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81.6%, 4.24%, 95.1%, and 20.5%, respectively (data not shown). The two UCB cell types A and 
B were also characterized by immunocytochemistry for different endothelial cell markers, 
namely CD31, VE-cad, and ac-LDL uptake (Figure 13B). The UCB cell population A presented 
only a few cells stained for CD31, some ac-LDL uptake and were negative for VE-cad, while 
UCB cell population B were positive for CD31, showed ac-LDL uptake, but had little expression 
of VE-cad. In terms of CD31 expression, these results are in accordance with the flow 
cytometry results, with UCB cells A being negative and UCB cells B being positive. 
 
Once again, UCB cells B expressed some ECs markers as described by other authors, while UCB 
cells A did not, since they should express CD31 in a great extent (39, 44-49). The morphology 
of UCB cells A and UCB cells B was also characterized by phase contrast microscopy. As 
depicted in Figure 13A, UCB cells A formed colonies, a feature described for OECs isolated by 
Silva et al (163) and had an elongated, fibroblast/mesenchymal-like shape, while UCB cells B 
presented a round shape and some were organized as multicellular agglomerates in certain 
regions of the well. The morphology of UCB cells A was another unexpected result. In fact, 
OECs are described as presenting a cobblestone-like morphology colonies that when isolated 
maintain the cobblestone-like morphology, similar to mature ECs. In contrast, UCB cells B 
have a morphology similar to that described for er-EPCs, being smaller and presenting a round 
shape (38).   
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Figure 13 – UCB cells A and B morphologic and phenotypic characterization. (A) Contrast phase 
images of UCB cells A and B (scale bar: 100 μm). a’ inset showing an UCB cell A with fibroblastic-like 
morphology in the periphery of a colony (scale bar: 10 μm). a’’ inset showing UCB cells A with a less 
elongated morphology (scale bar: 10 μm). a’’’ inset showing UCB cells B with round-shape (scale bar: 10 
μm). (B) Immunocytochemstry of UCB cells A and B stained with primary antibodies for CD31 and VE-
Cadherine, and Ac-LDL uptake (all in red). Nuclei stained with DAPI (in blue) (scale bar: 100 μm). 
 
 
Taken together, these results lead us to conclude that UCB cells B have apparently 
differentiated as expected, according to what is described in the literature, including by Silva 
et al (163), resembling er-EPCs. In contrast, the UCB cells A population seems to be a 
heterogeneous population, presenting a few endothelial-like cells, but being mainly 
constituted by mesenchymal-like or fibroblastic-like cells.  
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2. 3D cocultures of HUVECs and MSCs  
 
Our team has previously shown that MSCs in monoculture with 8 million/mL of cellular density 
were capable of producing their own ECM when cultured within RGD-alginate hydrogels with 
an optimized formulation (alginate 1% v/w with a ratio of 50:50 of HMW and LMW, with 200 
μM of RGD (90)). Later, studies on how HUVECs and MSCs interact with each other in 3D, when 
cultured in the same RGD-alginate hydrogels, where performed. Joana Bianchi’s thesis 
explored the cross-talk between these two cell types and described that when HUVECs and 
MSCs are both at 5 million/mL of cellular density in coculture within RGD-alginate hydrogels, 
they present higher metabolic activities and less cell death compared to both monocultures 
(5 million/mL of cellular density each). Moreover, their spatial rearrangement also changes 
when together. In coculture, these cells were able to significantly contract the hydrogel 
matrix, and to adopt some polarization of the actin filaments, with a superimposed mesh of 
Fn. Possibly, these changes were able to enhance HUVECs survival and drive them to form 
tubular structures in 3D, as observed by Bianchi’s work (unpublished results). 
Here, it was important to understand in more detail if MSCs were actually influencing HUVECs 
survival or if this effect would be only due to the increase of the cellular density (10 
million/mL for the coculture and 5 million for monoculture in Bianchi’s studies). Another 
important aspect to address was the culture time. Bianchi’s results were obtained after only 
1 and 3 days of culture, but it was important to know if the HUVECs survival and functionality 
could still be maintained after longer periods of time. In terms of a delivery system, the 
survival of cells along time is extremely important for a good therapeutic outcome. Following 
these questions, HUVECs and MSCs monocultures at 10 million/mL and HUVEC+MSC coculture 
at the same total density were established and maintained for 7 days in culture, being 
monitored at different levels. 
 
The metabolic activity of cells entrapped in alginate hydrogels was assessed at days 1, 3 and 
7. Figure 14A shows the metabolic activity values for 3D cultures of MSCs and HUVECs 
monocultures (10 million cells/mL), and HUVEC+MSC cocultures (10 million cells/mL of total 
density, each cell type at 5 million/mL), and also a theoretical value, corresponding to the 
sum of 50% of the values obtained with each monoculture. 
The metabolic activity of HUVECs in monoculture decreases along the time, showing that 
these cells do not survive well under the 3D conditions established in this study. A drop in the 
metabolic activity of HUVECs monocultures at 5 million/mL had already been shown in 
Bianchi’s thesis after 3 days of culture. Here, even if the cell density has been raised to 10 
million/mL, no significant improvements were detected, and very low values of metabolic 
activity were still observed day 7. In previous studies from Bidarra et al (124), HUVECs were 
cultured at 20 million/mL within similar hydrogels, and their viability only dropped 10% along 
2 days in culture, suggesting that in future studies higher cellular densities should be 
explored. In what concerns MSCs monocultures, their metabolic activity was higher than that 
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of HUVECs at day 1, and it was maintained essentially unchanged along the 7 days of culture. 
The opposite trend was reported in Bianchi’s work, where MSCs metabolic activity decreased 
along the 3 days of culture. Most likely, this difference can be again explained by the cellular 
density used. Maia et al (90) used 8 million/mL as cellular density that is very close to 10 
million/mL used here. However, in Bianchi’s work, the cellular density used was 5 
million/mL. In previous studies with MSCs, our group has demonstrated that higher cellular 
densities enhance MSCs activity in 3D, favoring cell-cell aggregation and production of 
endogenous ECM (112). Regarding the HUVEC+MSC coculture system, the metabolic activity 
slightly decreased from day 1 to day 3, being higher than the theoretical value. However, it 
decreased from day 3 to 7, reaching a value slightly below the theoretical level. Although it is 
not possible to discuss these differences in detail, as the values have not been normalized to 
the cell number, these results suggest that cells in coculture present acceptable levels of 
metabolic activity. 
 
 
Figure 14 – Metabolic activity and viability of HUVECs and MSCs in 3D cultures. (A) Metabolic activity 
assessed at day 1, 3 and 7 of culture of HUVECs and MSCs monocultures and HUVEC+MSC cocultures. The 
theoretical value expected for the cocultures is also presented (black bar). (B) Cellular viability at day 3 
of HUVEC+MSC and HUVECs alone assessed by LIVE/DEAD assay (cytrak orange in green (LIVE) and draq7 
in red (DEAD)) (scale bar: 100 μm). 
 
Figure 14B shows that the overall cellular viability was enhanced in HUVEC+MSC cocultures as 
compared with HUVECs monocultures. At day 3, it was possible to see that there were less 
dead cells (red) in cocultures as compared with HUVECs monoculture, where the number of 
dead cells was very high. This was also seen in Bianchi’s results and it was expected, since in 
the coculture system half of the cells are MSCs, which survive better in this type of 3D 
microenvironment contributing to an increase of the total cellular viability. 
At the macroscopic level (Figure 15), it was clear that a re-organization of cells rapidly 
occurred in the coculture system, as suggested by the contraction of the hydrogel matrix 
along the first 72 h of culture. 
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Figure 15 – Spatial re-organization of HUVECs and MSCs in 3D cultures. Images of the hydrogel 
matrices after 3 days in culture (red circles limiting disks periphery, scale bar: 500 μm) showing 
alterations at the macroscopic level (matrix contraction) and respective microscopic cellular 
organization (HUVECs labeled with cell tracker green® and MSCs with cell tracker blue®). Separate 
channels of coculture conditions show different cell migration pattern (grey scale) (scale bar: 100 μm). 
Matrix contraction is also presented in terms of percentage of contraction relatively to the original 
value.  
 
This effect was probably mostly driven by the MSCs, as the same behavior was detected in 
MSCs monocultures but not in HUVECs monocultures. To better understand the contribution of 
each cell type to the disk’s changes, MSCs were labeled with cell tracker blue™ and HUVECs 
with cell tracker green™. In fact, in the coculture, it is possible to see that MSCs (in blue) 
migrated towards the center of the disk and are closer to each other when comparing with 
HUVECs (in green), confirming our hypothesis. This can be even more clearly seen in the 
separated channels image (grey scale) that better depict the behavior of each cell type in 
terms of migration/aggregation. A high level of cell-cell aggregation, and matrix contraction, 
was also detected in MSCs monoculture, where cells also migrated to the center of disk 
forming a multicellular aggregate. In this case, the level of matrix contraction was even 
higher than that observed in the coculture system, as seen in Figure 15. This difference can 
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be explained by the number of MSCs, which was lower in coculture conditions. As suggested 
by previous results from our group (90), this cell migration towards the center of the disk 
creates a new microenvironment that certainly has an impact in HUVECs behavior. In 
particular, this process has been shown to be accompanied by the deposition of a Fn mesh, 
forming a microtissue (90). As already demonstrated, this effect is highly dependent on the 
viscoelastic properties of the hydrogel, occurring only within very soft matrices as the ones 
used in this study, and on the cellular density (112) (Neves et al, 2014, submitted). In HUVECs 
(in green) monocultures this phenomenon did not occur. Disks maintained the original size 
and cells remained dispersed throughout the matrix. 
 
When cultured together, HUVECs and MSCs formed some clusters of cells within the hydrogel 
at day 1 that were not seen neither in HUVECs, nor in MSC monocultures (Figure 16). At day 
3, the differences between the different formulations were even more pronounced. The 
morphology and distribution of HUVECs remained similar to that observed at day 1, showing a 
lack of cellular reorganization. In the coculture system, it was possible to see a complex 
structure that seemed to be growing outward the disk center, composed mainly of HUVECs (in 
green), suggesting that HUVECs are capable of re-organizing themselves within the hydrogel 
matrix. Unfortunately, these structures could no longer be detected at day 7 (data not 
shown), suggesting that their stability in vitro was lost after a certain period of time. In 
Figure 14B, it was seen that the overall cell viability was higher in coculture than HUVECs in 
monoculture, but it was not possible to distinguish between the two cell types. However, in 
this assay, a viability dye (DRAQ7, which do not permeates intact cell membranes) has been 
used in conjunction with the two cell trackers allowing a more detailed analysis of cellular 
viability. For MSCs, it seems that cell death was almost equal for monoculture and coculture. 
However, HUVECs showed some changes in cell viability. At day 1, in HUVECs monoculture, a 
great percentage of cells are dead or with compromised viability, contrasting with cocultures, 
where a lower percentage of HUVECs showed DRAQ7 permeation, particularly within the cell 
clusters. The same trend was also seen at day 3, where some HUVECs are stained in red, but 
not those within the multicellular structures. Thus, the coculture with MSCs seemed to 
contribute to the enhancement of HUVECs survival and function. 
72 
 
Figure 16 – Cellular re-organization in 3D. Confocal microscope images of HUVECs, MSCs and 
HUVEC+MSC cultures at days 1, 3 and 7. HUVECs were labeled with cell tracker green, MSCs with cell 
tracker blue, and Draq7 was used to detect dead cells. (scale bar: 100 μm) 
 
The spatial cellular reorganization detected at day 3 was analyzed in more detail by labeling 
ECs with ac-LDL (Figure 17). In this way it was possible not only to detect HUVECs inside the 
disks, but also to address their functionality. When cocultured with MSCs, HUVECs form 
clusters inside the disk, detected by the intense levels of fluorescence at well-defined spots 
(Figure 17A). It was also possible to detect some tubular-like structures, often coming out 
from these clusters, showing that HUVECs, in the presence of MSCs, are able to reorganize 
and maintain functionality. In a higher magnification (Figure 17A), it is possible to see the 
alignment of HUVECs forming these tubular-like structures and their distribution in the z-axis, 
forming a three-dimensional network (Figure 17B). Figure 17 also shows that MSCs (in blue) 
are in close contact with HUVECs.  
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Figure 17 - HUVECs 3D arrangement and functionality. (A) Ac-LDL uptake and organization of HUVECs 
in monoculture and coculture at day 3. In monoclutures nuclei appear in blue (DAPI) and HUVECs in red 
(ac-LDL), in cocultures, MSCs appear in blue (cell tracker blue®) and HUVECs in red (ac-LDL) (scale bar: 
100 μm). (B) Higher magnification images showing of aligned HUVECs aligned into tubular like structures 
in close proximity with MSCs. (scale bar: 10 μm) 
 
Although they appear to exert a benefic effect over the cocultured HUVECs, the exact role(s) 
of MSCs remain unclear. As shown, MSCs promote HUVECs function, somehow providing them 
with cues that promote their assembly into organized structures. In the literature, MSCs have 
been described as mural cells that support other cellular types like HSCs, contributing for the 
bone marrow stem cell niche (168).  
As mural cells, MSCs are known to produce ECM matrix and growth factors that stimulate, 
help, and respond to ECs (169). Fn is one of the most important proteins having a crucial role 
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in angiogenesis (103). Normally, ECs interact with a basement membrane rich in laminin, but 
when an angiogenic stimulus occur, Fn interact with ECs, working as a provisional matrix that 
is going to mediate proliferation and migration of ECs (170-171). Indeed, in a previous study 
from our group, Bianchi et al demonstrated that MSCs are able to assemble a Fn-rich network 
inside soft alginate hydrogels, both in monoculture and in coculture with HUVECs, which 
probably has a key role in promoting the organization of ECs into tubular-like structures.  
MSCs have been also shown to be implicated in the stabilization and support of blood 
capillaries, acting as PCs or PVCs (83, 172). Indeed, some authors defend that all MSCs are 
PCs and contribute for the formation of new vasculature (71). It has been shown that PCs 
express the same markers as MSCs, and are able to differentiate into the three lineages 
related with MSC: osteogenic, chondrogenic and adipogenic lineages, showing that PCs are 
multipotent cells (71). These PCs that share a phenotypic profile with MSCs are found in the 
vasculature of all tissues in the body. Crisan et al (71) have explored the presence of these 
cells in human skeletal muscle, pancreas, placenta, white adipose tissue, heart, skin, lungs, 
among others, and all shared the same phenotypic markers. Indeed there are many evidences 
that PCs and MSCs are closely related or are the same cell. However it is not quite obvious if 
PCs come from MSCs, or if PCs are the cells less differentiated that can differentiate into 
MSCs. Not only these cells are found in the vasculature of tissues, but they are known to 
participate in the regeneration of wounded tissues, as MSCs are too (71). Here, we analyzed 
the expression of α–SMA, often considered as a PCs and PVCs marker (72, 173). As shown in 
Figure 18, MSCs are in fact expressing α–SMA. Some MSCs with spread-shape morphology that 
resemble that of PCs/PVCs-like cells were also detected, even if we were not able to detect 
them co-localizing with ECs structures. Although further studies have to be conducted to draw 
a convincing conclusion, these results suggest that MSCs in the coculture system might 
actually be acting as PCs/PVCs-like cells. However, this seems to be insufficient for the 
maturation of the ECs tubular structures, given that these were no longer detected after 7 
days. 
 
 
  
Figure 18 – MSCs functional behavior as PCs/PVCs cells in 3D. Immunocytochesmitry of α–SMA in 
cocultures of HUVECs (at green) with MSCs (at blue) at day 3 (scale bar: 100 μm). Inset (from the yellow 
square) showing a MSC with spread-shape morphology colocalizing α–SMA (scale bar: 10 μm). 
 75 
David Boaventura Teixeira Gomes 
3. 3D cultures of UCB Cells A and MSCs 
 
Although we have been unable to fully characterize the phenotype of UCB cells A, we have 
decided to investigate the behavior of these cells in our 3D culture system, both in 
monoculture and in coculture with MSCs. After entrapment within the hydrogel, the 
metabolic activity of these cells was assessed after 4 hours, and at days 1, 2 and 3 (Figure 
19).  
 
 
 
Figure 19 – Cellular metabolic activity and macroscopic organization of UCB Cells A and MSCs in 3D. 
(A) Metabolic activity of MSCs and UCB cells A in monocultures and in UCB cells A+MSC colculture after 4 
h, and 1, 2 and 3 days after embedding. The theoretical value for the coculture is also represented in 
the graph in the black bar. (B) Macroscopic changes after 3 days in culture (scale bar: 500 μm). UCB 
cells A +MSC are depicted in a higher magnification at right (scale bar: 100 μm).   
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As depicted in Figure 19A, and in contrast with that observed for HUVECs, UCB cells A, were 
able to survive well in a 3D environment. Despite the slight decrease in metabolic activity 
observed after the first 24h, which is probably related with the embedding process and the 
adaptation of the cells to the new environment, UCB Cells A presented constant levels of 
metabolic activity until day 3. The same was observed in MSCs cultures, similarly to what had 
been previously shown in Section 2, and in the UCB cells A+MSC coculture. Yet, the 
theoretical value was always higher than the coculture value. As depicted in Figure 19B, 
which shows the macroscopic appearance of the disks after 3 days, extensive matrix 
contraction occurred in all conditions, including UCB-derived Cells A, which is a striking 
difference compared to the behavior of HUVECs. This result shows that these cells are able to 
exert traction/pulling forces in the matrix, which is a common feature of mesenchymal- and 
fibroblastic-like cells. The contraction of the coculture disks was higher than that of each 
individual monoculture, suggesting that both cell types are acting synergistically. So, 
effectively, UCB Cells A seem to behave more as mesenchymal or fibroblastic-like cells than 
as endothelial-like cells, as previously noticed. 
 
In contrast with what was seen with MSCs monoculture, where the traction/pulling forces 
lead to the formation of a spherical mass at the center of the disk, UCB cells A in 
monoculture formed a more complex structure, with an elongated shape, that crossed the 
center of the disk from one edge to the other (Figure 20). This structure seemed to be quite 
well organized in terms of cellular alignment, with cells exhibiting actin filaments assembled 
with a specific orientation, while the cells outside this structure lack actin filaments 
organization. As it was described in Section 1, UCB cells A in 2D seem to have some ability to 
uptake ac-LDL. In 3D, some ac-LDL uptake was also detected, along with the expression of 
the ECs marker vWF, which was detected at very low levels at day 3. However, the expression 
of CD31 was not detected, similarly to that previously observed in 2D. So, strikingly, UCB cells 
A present a behavior that is similar to mesenchymal-like, fibroblastic-like cells or even SMCs, 
all of which have been already isolated from UCB (174-175), but concomitantly express, even 
if at low levels, some endothelial markers that are not characteristic of those cell types. 
 
 
Figure 20 – UCB cells A phenotype and rearrangement in 3D. CLSM images of cell-laden hydrogel disks 
immunostained with primary antibodies for vWF, actin and CD31, and marked with ac-LDL uptake, at 
days 1 and 3 (scale bar: 100 μm). 
 77 
David Boaventura Teixeira Gomes 
In UCB cells A+MSC coculture, and as depicted in Figure 19B, some multicellular structures 
are growing outwards the center of the disk. These can be more easily observed in Figure 21, 
which shows the development of these structures in more detail, at days 1 and 3 of culture. 
 
 
 
Figure 21 – UCB cells A and MSC cocultures: phenotype and rearrangement in 3D. CLSM images of 
cell-laden hydrogel disks immunostained for actin and labeled for ac-LDL uptake at days 1 and 3 (scale 
bar: 100 μm). 
 
Actin staining shows that cells started aligning thus adapting their cytoskeleton to these 
organized structures. However, only at day 3 it was possible to detect cells with actin 
filaments with a specific orientation and cells arranged as multicellular structures, 
incorporating some ac-LDL-positive cells. Interestingly, such sprouting structures where not 
seen in UCB cells A or MSC monocultures (data not shown). So, it seems that the cross-talk 
between the two cell types promoted their formation. However, further characterization of 
UCB cells A both in 2D and in 3D has to be performed using complementary assays in order to 
better characterize these cells, and also to rule out the possibility of occurrence of technical 
artifacts. 
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4. 3D cultures of UCB cells B/HUVECs and UCB cells B 
/HUVECs/MSCs 
  
In a 3D coculture microenvironment even if er-EPCs are not able to form vessels, they might 
secrete the appropriate factors (37) that will in turn stimulate ECs to form tubular-like 
structures. 
Here, UCB cells B, which resemble er-EPCs, were cultured alone and in coculture with 
HUVECs and their metabolic activity was monitored along time (Figure 22). The metabolic 
activity of UCB cells B in monoculture decreased along the culture time, similarly to what has 
been observed for HUVECs, suggesting that these cells have a low survival rate when cultured 
alone in a 3D microenvironment. Moreover, they do not seem to contribute for HUVECs 
survival when in coculture, since, in this case, the metabolic activity in the coculture system 
also significantly decreased along the time. 
These results can possibly be explained by the lack of newly-formed matrix. In the case of 
MSCs+HUVECs it was seen that MSCs enhance HUVECs survival, in part by producing Fn and 
probably other ECM proteins that apparently contribute to maintain HUVECs survival and 
function (Bianchi’s thesis). In the absence of MSCs and their secreted ECM, HUVECs viability 
and metabolic activity in 3D are compromised. Thus, even though EPCs might secrete 
important factors that would be capable of enhancing HUVECs survival in 2D, this might be 
insufficient in such 3D environment.   
 
 
Figure 22 – Cellular metabolic activity of UCB cells B. UCB cells B and HUVECs in monocultures and of 
UCB cells B+HUVEC coculture after 4 h, and 1, 2 and 3 days after embedding. The theoretical value for 
the coculture is also represented in the graph (black bar). 
0
2000
4000
6000
8000
10000
12000
14000
16000
4h day 1 day 2 day 3
C
e
llu
la
r 
m
e
ta
b
o
lic
 a
ct
iv
it
y 
(A
FU
)
UCB cells B HUVEC HUVEC+UCB cells B Theoretical value
 79 
David Boaventura Teixeira Gomes 
 
Although we did not see any positive effect of UCB cells B in cocultured HUVECs, we decided 
to investigate if these cells could eventually display any synergistic effect in HUVEC+MSC 
cocultures, by promoting, for example, the formation and/or stabilization of ECs tubular 
structures. In fact, Burlacau et al (176) described that MSCs and er-EPCs have complementary 
paracrine effects on ECs. In particular, while MSCs support ECs adhesion, but not 
proliferation, EPCs promote proliferation, but do not sustain ECs adhesion. 
Figure 23A shows the metabolic activity of MSC+HUVEC+UCB cells B triple-cultures along 
time. Although there was a significant decrease in metabolic activity after the first 24h in 
culture (-39%), from day 1 to day 2 the decrease was only -4% and from day 2 to day 3, there 
was no further decrease. This trend was not observed in either MSCs or HUVECs monocultures. 
As seen before, HUVECs presented higher cell death, while MSCs tend to have a high 
metabolic activity, but presented a higher decrease along the culture, namely ca. 14% 
between days 2 and 3. These results suggest that UCB cells B had a positive impact on the 
cells metabolic activity and survival in the triple-culture system. Even though 
MSC+HUVEC+UCB cells B do not have values higher than the theoretical value, it was the only 
condition presenting a rather constant metabolic activity over time.  
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Figure 23 – Cellular metabolic activity and macroscopic organization of UCB Cells B, MSCs and 
HUVECs in 3D. (A) Metabolic activity of MSCs and HUVECs in monocultures and in UCB cells 
B+MSC+HUVEC triple-culture after 4 h, and 1, 2 and 3 days after embedding. The theoretical value for 
the coculture is also represented (black bar). (B) Macroscopic changes after 3 days in culture (scale bar: 
500 μm). UCB cells B+MSC+HUVEC are depicted in a higher magnification at right (scale bar: 100 μm).    
 
 
As depicted in Figure 23B, an extensive contraction of the hydrogel matrix was observed in 
the triple-culture, which was even higher than the contraction of MSCs monoculture disks. 
The presence of organized multicellular structures sprouting from the center of the disk could 
be observed at higher magnification (on the right). Since such dramatic changes were not 
previously observed in HUVEC+MSC cocultures, it is reasonable to assume that UCB cells B 
played a role on this process. In fact, Shi et al (177) described that when er-EPCs were triple-
cultured with MSCs and OECs, the formation of prevascular structures at early stages of 
culture was enhanced, showing that er-EPCs have a synergistic effect in ECs-MSCs crosstalk, 
promoting ECs function. 
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Since CD45 is expressed by UCB cells B, but not by MSCs, nor HUVECs, this marker was used to 
distinguish between UCB cells B and other cells. Figure 24A shows that UCB cells B were 
widely distributed in the disk and in close proximity with the other cells, which is a relevant 
feature as it will certainly facilitate any paracrine effect that they might have over the other 
cells, particularly HUVECs. Indeed, the same effect was described for triple-cultures of MSCs, 
OECs and er-EPCs (177). Er-EPCs were found to be closely associated with angiogenic 
structures (in the tip or around vascular structures), suggesting their active role in the 
formation of vascular structures that can indicate the tight paracrine relation that er-EPCs 
can exert on ECs and MSCs (177). 
  
 
 
Figure 24 – 3D spatial rearrangement of cells in a UCB cells B+MSCs+HUVECs triple-culture. (A) 
Imunnocytochemistry of CD45 with DAPI at day 1 f culture (B) Imunnocytochemistry of VE-cad marked 
with DAPI at day 1 and 3 of culture (sacle bar: 100 μm). 
 
 
 
To investigate HUVECs organization and functionality in the triple-culture system, the 
expression of VE-cad was analyzed, as this is an important EC marker implicated in the 
cohesion and organization of intercellular junctions, being indispensable for proper vascular 
development. Figure 24B shows that cells at day 1 did not present a specific organization and 
expressed low levels of VE-cad at the cell membrane. At day 3, however, VE-cad was 
expressed at the cell membrane in a network of ECs, confirming the tight interaction 
between them.  
The EPC+HUVEC+MSC triple-culture was also stained for α-SMA expression at days 1 and 3 of 
culture (Figure 25). At day 1, the disks presented a lack of cell organization, but some α-SMA 
expression (in white) was detected throughout the disk, suggesting a homogeneous 
distribution of MSCs. Yet, α-SMA filaments were not fully organized, and did not display any 
specific orientation. 
  
82 
 
Figure 25 – UCB cells B, MSC, and HUVEC triple-culture 3D rearrangement. Imunnocytochemistry of 
vWF and α-SMA marked with DAPI and ac-LDL uptake at day 1 and 3 of culture (sacle bar: 100 μm). 
 
However, at day 3, α-SMA filaments showed some alignment, and were in close proximity of 
cells that uptake ac-LDL and were positive for vWF expression – two major endothelial 
markers – which may indicate that MSCs were interacting with HUVECs. 
 
Although the images have been obtained at the disks surface, the sprouting structures seen in 
Figure 23B (inset at higher magnification) were not possible to detect. During culture time, 
with the shrinking and reorganization of the disks, they fold under themselves, which posed 
some technical problems that unable the imaging of those structures. Even though, the new 
system described herein, which explores the cross-talk between HUVECs, MSCs and UCB cells 
B (that presumably are er-EPCs) might be potentially interesting for pro-angiogenic therapies. 
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Results and Discussion – Part II - 
Bioprinting of alginate-based bioinks 
 
1. Rheological characterization of alginate solutions 
 
The LAB technique is highly dependent of bioink’s viscosity. The higher the viscosity, the 
higher the inertia felt by the solution during bubble formation. In order to overcome that 
extra inertia, more energy power has to be used. In what concerns the bioinks tested here, 
and as depicted in Figure 26, the viscosity of 2% (w/v) alginate solutions was higher than that 
of 1% (w/v) solutions, as expected. Also, the viscosity seemed to increase with the cell 
density. This may be explained by the presence of cells within the hydrogel, which behave 
like “particles” contributing to the viscous properties of the solution, as previously seen in 
other studies (159). 
 
 
 
Figure 26 – Viscosity analysis. Viscosity of 1% and 2% (w/v) alginate solutions containing CaCO3 and MSC 
at two different densities (2 and 15 million/mL). Left: Shear rate ramp; Right: single shear rate analysis.  
  
Single shear rate (10 s-1)Shear rate ramp
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2. Printing behavior of alginate solutions 
 
In order to test the printability of alginate solutions; a preliminary assay was carried out using 
the 2% (w/v) alginate solution, since this solution was the most viscous one and would be in 
principle the most difficult to print. So, the laser conditions were initially tuned and analyzed 
with this formulation. A thickness of 20 μm was chosen for the solution layer, along with a 
standard laser energy of 28 A. As it is possible to see in Figure 27, all the expected printing 
steps occurred (153), namelly: 1) bubble formation (3 μs), 2) bubble collapsing (5 μs), 3) jet 
forming (10 μs), and 4) landing (50 μs). All the steps occurs within just 800 μs, showing not 
only that the tested alginate formulation was printable, but also that the printing process 
progressed in a HT manner, in less than 1 ms. 
 
 
 
Figure 27 – TRI images taken over time. The images show the different stages of the printing process: 
1) bubble formation (3 μs), 2) bubble collapsing (5 μs), 3) jet forming (10 μs), and 4) landing (50 μs). 
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3. Optimization of the bioprinting process 
  
3.1. Morphology of the hydrogel spots 
 
As described by Guillemot et al (153), the mechanical stress the cells suffer upon laser 
printing is the main factor affecting cellular viability during the printing process. Therefore, 
it was necessary to optimize the laser energy to be as low as possible, since more energy 
power leads to more mechanical stress. To address this, different laser energies were tested, 
namely 12, 23, 35, 46 and 58 μJ, and their effect on the hydrogel spots morphology and 
diameter was evaluated. This was performed using both alginate formulations (1% and 2% 
(w/v) alginate), which were spread in quartz slides (Figure 28 and 29). 
 
Figure 28 – Energy power effect in bioprinted spots formation. In the first row: 1% (w/v) alginate. 
Second row: 1% (w/v) alginate with GDL and CaCO3. Third row: 1% (w/v) alginate with GDL and CaCO3 
and MSC at 15 million/mL.  
 
As shown in Figure 28, 1% (w/v) alginate solutions were printable at the majority of the 
tested laser energies, except for the lowest and the highest values of 12 and 58 μJ, 
respectively. It seems that the energy of 12 μJ was insufficient to achieve the jetting regime. 
The opposite was observed at 58 μJ, where it was possible to see that only tiny droplets were 
formed, which are probably caused by a plume regime. Since one of the aims was to have a 
system that self-gelates after printing, the same energy spectrum was tested using 1% (w/v) 
alginate containing CaCO3 and GDL. However, under such conditions, no printing was observed 
at none of the tested energies, because the bioink was not spreadable at the ribbon. This may 
be explained by differences in surface tensions that arise upon addition of CaCO3 and GDL, 
but further confirmation has to be done in future studies. Finally, cell-loaded bionks were 
tested, and a preliminary printing with a cellular density of 2 million MSCs/mL in 1% (w/v) 
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alginate with CaCO3 and GDL was performed (Annex 1). Once again, this bioink was printable 
at all the energies, with exception of 12 and 58 μJ. Yet, while some hydrogel spots were well 
defined, others had an irregular shape and/or fused. Later, the process was repeated using 15 
million MSC/mL (Figure 28) and the same printing pattern was obtained. Although the spots 
obtained at 23, 35 and 46 μJ showed almost the same morphologies, the 35 μJ seemed to be 
the condition where the spots were in general more regular. The same process was repeated 
for the 2% (w/v) alginate solution (Figure 29). 
 
 
Figure 29 – Energy power effect in bioprinted spots formation. In the first row: 2% (w/v) alginate. 
Second row: 2% (w/v) alginate with GDL and CaCO3. Third row: 2% (w/v) alginate with GDL, CaCO3 and 
MSC (red) at 15 million/mL.  
 
In this case, since there was an increase in the alginate concentration, 12 and 23 μJ proved to 
be insufficient energies to print adequate hydrogel spots in all the three conditions. 
Regarding the condition with 15 million MSCs/mL, 35 μJ seemed again to be the best laser 
energy for printing, since 46 and 56 μJ present some droplet abnormalities and 23 μJ seemed 
to give rise to very small hydrogel spots with few cells inside. Taking into consideration the 
results depicted in Figure 28 and 29, the energy chosen for the subsequent experiments was 
35 μJ for both alginate concentrations. 
 
3.2. Diameter of the hydrogel spots 
 
The diameters of the hydrogel spots were measured for both alginate formulations, with and 
without cells (Figure 30). As expected, the average diameter of 1% (w/v) alginate spots is 
higher than those at 2% (w/v). This is probably related with the higher viscosity of the 2% 
(w/v) solution, which acts as an opposite force to bubble expansion. Also, at higher 
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viscosities, the hydrogel tends to recover better its shape, leading to a higher resistance to 
jet formation. The average diameter decreases in both formulations when cells are added, 
which is, again, probably explained by the associated increase in viscosity. 
 
 
Figure 30 – Average diameters of the hydrogel. Hydrogel spots obtained with 1% and 2% (w/v) alginate 
solutions, without and with cells at 15 million/mL. 
 
3.3. Volume of the hydrogel spots 
 
Another important parameter is the hydrogel spots volume, which enables to estimate the 
real cellular density inside the gel spot. Figure 31 shows the TRI images from which spots 
heights and diameters were obtained for the subsequent calculation of the spots volume. 
With these values, summarized in Table 4, it was possible to estimate the average cellular 
density of each printed alginate formulation. As expected from the previous results, the 2% 
(w/v) alginate spots presented lower volumes. In terms of cellular density, the 2% (w/v) 
alginate spots presented in average 28.2 million/mL, while the 1% (w/v) alginate spots 
presented in average 44.7 million/mL. Yet, even if the errors associated with the volume 
calculations were not very high, the values for the number of printed cells were very irregular 
and greatly affected the calculated densities, which are thus unreliable. This will have to be 
further optimized in the future. 
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Figure 31 – Measurement of the height and diameter of hydrogel droplets from TRI images. Table 4 
shows the hydrogel spots height and volume, the approximate number of printed cells, and the 
approximate cellular density for both alginate formulations. 
  
4. In vitro culture of cell-laden hydrogel spots 
 
After optimizing the printing conditions, MSCs-laden hydrogel spots were printed directly  
onto LabTek® slides and cultured under standard in vitro conditions. In this case, hydrogels 
were made of RGD-modified alginate, in order to promote cell-matrix adhesion. 
4.1. Stability of hydrogel spots in culture 
 
Since the hydrogel spots have to remain attached to the receiving substrate along the period 
of culture, a preliminary analysis on the spots stability over one week of culture was made. In 
order to have a stable microarray, LabTek® slides were pre-coated with PLL, which confers a 
positive charge to the surface and interact electrostatically with the negatively charged 
alginate droplets promoting an adequate spot-substrate adherence. After printing, the slides 
with attached spots were maintained for 7 days in cell culture medium, under standard 
incubation conditions, and pictures were taken over time. 
Figure 32 shows that the hydrogel spots can be easily monitored during the culture period. 
Also, and more importantly, it shows that microarray can be maintained under standars 
culture conditions for at least one week, as the hydrogels spots remain attached to the 
substrate. 
 
1% HLMW (w/v) 2% HLMW (w/v)
Diameter Height
Table 1 – Cellular densitycalculation
Height (μm) Volume (pL)
Aproximate Number of 
Printed Cells 
Aproximate Cellular
Density (millions/mL)
1% HLMW 
(w/v) 
23 ± 0.5 107.7 ± 2.4 4.5 ± 1.5 44.7 ± 14.1
2% HLMW 
(w/v) 
25.4 ± 1.2 73.0 ± 3.9 2.1 ± 1.4 28.2 ± 19.4
2Table 4 – Cellular i Calculation
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Figure 32 – Hydrogels stability. Stability of hydrogels spots attached to a PLL-coated LabTek® slides 
over 7 days of culture. The area of the spots is indicated by the dashed line circles. 
 
 
 
4.2. Viability of bioprinted cells 
 
One of the main problems of the LAB technique is that the printing process can detrimentally 
affect cell viability. In order to evaluate this possibility, the viability of the printed cells was 
analyzed by the LIVE/DEAD assay. As depicted in Figure 33, cells within the hydrogel spots 
remained alive after 7 days of culture, in both types of hydrogel formulations, as showed by 
the green fluorescence-staining from internalized calcein. These results were in accordance 
with the MT assay, which was used as a control, where entrapped cells also remained alive. 
 
  
Figure 33 – Bioprinting cellular viability. Viability of MSCs entrapped in RGD-alginate hydrogels, after 7 
days of culture in basal medium, in HT and MT formats, indicated by the green fluorescence of 
internalized calcein (LIVE/DEAD assay). HT: high-throughput; MT: medium-throughput. White circles 
indicate the area of the spots. 
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4.3. Validation of the microarray platform 
 
In order to validate the use of the proposed HT platform in future studies it was important to 
guarantee that the behaviour of cells in this microarrays (cell-laden hydrogel spots) 
replicated the one typically observed in standard MT assays (cell-laden hydrogel disks). With 
this aim, we decide to analyze if this system supported the differentiation of entrapped MSCS 
into the osteoblastic lineage, as previously reported by our group for the hydrogel disks (90). 
Cell-laden hydrogels were cultured in osteoinductive medium and, after 7 days, MSCS 
osteogenic differentiation was assessed through the analysis of ALP activity expression. As 
depicted in Figure 34, MSCS entrapped in 1% (w/v) alginate hydrogel spots formed aggregates 
and expressed higher ALP activity than MSCS in 2% (w/v) RGD-alginate hydrogel spots. These 
results are in accordance with the ones obtained with the MT assay, depicted in the same 
figure (90). 
 
 
Figure 34 – Osteogenic differentiation assessment. ALP activity staining (dark pink) after 7 days of 
culture in osteogenic medium of cells cultured within both types of alginate formulations, HT and MT 
set ups. HT: high-throughput; MT: medium-throughput. Black circles indicate droplet’ place and the red 
scales represent 50 μm.  
 
5. Co-printing of ECs and MSCs 
 
After optimizing the bioprinting and culture conditions for the MSCs-laden hydrogel 
microarrays, the feasibility of co-printing two cell types, MSCs and ECs, was evaluated. Cells 
were suspended in 1% (w/v) RGD-alginate hydrogels, at 50 million/mL of final cellular density 
and printed as previously described. As depicted in Figure 35, the obtained hydrogel spots 
were effectively loaded with the two types of cells, which were in close proximity. 
200 μm
1% HLMW (w/v)
MTHT
200 μm
HT MT
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200 μ
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Figure 35 – Co-printing of ECs and MSCs. Left: fluoresce microscopy image of hydrogel spots showing 
entrapped MSCs expressing Tomato Fluorescent Protein (red); Center: Bright-field image of hydrogel 
spots with MSCs and ECs. Right: merged image, showing MSCs (red) and unlabeled ECs. (Scale bar: 200 
μm). 
 
Unfortunately, due to time constrains, it was not possible to advance further with the 
implementation of these coculture microarrays for the study of EC-MSC interactions in 3D. As 
it was demonstrated by Gruene et al (161), the development of this kind of microarrays has a 
great potential for tissue engineering to unravel how cells communicate with artificial 
biomimetic ECMs and how they communicate with each other. In this article, Gruene et al 
(161) show that direct cell–cell contacts trigger the development of stable vascular-like 
networks within spots around 200 μm. The number of cells and material used in this kind of 
techniques is so small that makes possible the up scaling of complex 3D experiments that are 
crucial for a more deep understanding of cell-cell and cell-matrix communication. 
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Conclusions and Future Work 
 
Aiming towards the creation of a suitable ECs delivery system that could promote the neo-
vascularization of injured/ischemic tissues, the goal of this work was to optimize, in vitro, 3D 
microenvironmental conditions that could improve ECs survival, as well as promote their 
capability to form tubular-structures. Using parameters already optimized by our team for 
HUVECs 3D culture, namely regarding the mechanical properties of the artificial ECM-like 
hydrogels and the density of available RGD peptides, a 3D system where ECs were combined 
with MSCs as supportive cells was successfully established in previous studies. 
Despite these advances, a number of issues remained to be elucidated and further 
optimization of some parameters was still required. Here, additional studies were conducted 
to find an alternative source of ECs, as HUVECs are unsuitable for clinical applications due to 
their complex harvesting process and lower expansion potential. As alternative, we 
attempted to isolate two distinct populations of endothelial progenitor cells, early- and late-
EPCs (or OEC) from UCB samples. Although we had difficulties to reproduce the 
differentiation protocol described in a previously published study, two different populations 
were isolated and characterized: UCB cells A, which presented both endothelial and 
mesenchymal/fibroblastic features; and UCB cells B which resembled early-EPCs. Both were 
used in subsequent 3D studies. 
The important role of MSCs when in coculture with the different cell types was confirmed. In 
what concerns MSC+HUVEC cocultures, this study demonstrated that the differences between 
the mono- and cocultures effectively resulted from MSCs-HUVECs cross-talk and were not 
related with the total cell density. Expression of α-SMA suggests that MSCs might actually act 
as PCs/SMCs. Yet, although tubular structures were detected in MSC+HUVECs cocultures, their 
stability was lost after some days in culture. In future studies it will be important to extend 
their stability towards the formation of mature ECs structures, which might eventually be 
achieved by increasing even further the total cell density and/or change the MSCs/HUVECs 
ratio. In coculture with UCB cells A, MSCs seemed to assist the organization of these cells in 
3D, resulting on the significant contraction of the hydrogel matrices and the formation of 
sprouting structures which were not present in UCB cells A monocultures. UCB cells B 
resembled er-EPCs, regarded as cells with paracrine potential to enhance ECs survival, but 
were not able to enhance HUVECs survival in coculture. However, these cells seemed to have 
a positive effect when triple-cultured with HUVECs and MSCs, HUVECs, which behavior was 
different from HUVECs+MSCs coculture, promoting a striking contraction of the hydrogel 
matrix with formation of sprouting structures, and also a tight interacting between HUVECs in 
proximity with MSCs expressing α-SMA. 
 
Even thought we were able to isolate different cell populations with potential advantages for 
endothelial delivery and/or in situ endogenous stimulation, a more detailed characterization 
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of these populations must be carried as future work. Both UCB cells A and B have to be 
characterized regarding their doubling time, senescence, telomerase activity, and protein 
production, and in more detail, UCB cells A phenotype have to be further characterized by 
analyzing the expression of alternative endothelial markers along with 
fibroblastic/mesenchymal/SMC markers. Also, to overcome the difficulty of obtaining OECs, 
the use of cloning cylinders for harvesting cell colonies might present a good alternative for 
the standard cell trypsinization used in this work. In fact, after forming colonies, UCB cells A 
were harvest by trypsinization of the entire well, which could have led to contamination of 
the obtained population with fibroblastic/mesenchymal cells or SMC present outside the 
colony. Achieving a well-characterized OECs population would enable us to study the behavior 
of these cells in 3D, mono-, cocultured with MSCs, and triple-cultured with MSCs and er-EPCs 
as a fully competent ECs delivery system capable of providing supportive cells, endothelial 
stimulating cells (er-EPCs) and mature ECs (OECs). 
 
Despite some new conditions and parameters could be optimized here, 3D cultures still 
continue to face the problem of being a technical challenging system. The amount of material 
and the number of cells that are needed to make these 3D systems lead to very slow 
progresses in finding an optimal approach for an ECs delivery system. As a solution, in the 
second part of this work, we aimed at developing a HTS platform, consisting on bioprinted 
cell-in-gel 3D microarrays that were prepared using the LAB technique. This was the first time 
that such an approach was tested and the developed microarrays are expected to serve us as 
a powerful tool for analyzing cell-ECM cross-talk behavior in 3D. Indeed, it was possible to 
replicate some previous results typically obtained with the standard MT approach (hydrogel 
discs), which was important for the validation of this new system. Not only it was possible to 
test different conditions in terms of alginate viscoelastic properties and cell densities, as it 
was also possible to co-print HUVECs and MSCs. 
Although this study represents a first step towards the development of the proposed HTS 
platform further optimizations are needed. Some drawbacks, such as the difficulty to 
accurately control the droplets diameters and the high variability of cell numbers within the 
droplets, present inconsistencies to the final results that have to be further overcame. As 
future work we are planning to design a new bioprinter, in collaboration with Dr. Paulo 
Bartolo’s team, at the Centre for Rapid and Sustainable Product Development (CDRSP). The 
aim is to develop a custom-made bioprinter integrating some important features, such as 
allowing different formulations of bioinks to be printed in the same chamber of a LabTek® (to 
more easily allow combinatorial analysis); and with the possibility of being used within a flow 
chamber hood. 
We are also planning to carry out some modifications in our hydrogel formulations, in terms of 
the gelling mechanism. To avoid the limitation of having a working time window for the 
bioprinting process, as the current formulations start to gellify with time, we are planning to 
study a different gelation system. The idea is to use a photoacid generator (PAG) – 
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diphenyliodonium nitrate – that is triggered only by UV-light (178). This molecule would 
replace GDL, so that we could start the gelation on-demand, making the system even more 
controllable. With a more robust system it would be possible to combine different cell types 
(e.g. OECs, er-EPCs and MSCs) in a single droplet and more easily analyze the best conditions 
to promote the formation of stable ECs tubular structures to be further explored in vivo. 
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 Annex I – Laser power influence in printing 1% HLMW (w/v) alginate with 
gelation agents and cells at 2 million/mL as cell density 
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